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7.0 Abstract 
It is estimated that one out of four couples in developed countries are affected by infertility.  
Assisted reproductive technologies (ART) have made crucial advancements in helping couples 
achieve the goal of parenthood.  However, one of the many challenges facing this patient 
population is the failure of embryo implantation into the uterus during in vitro fertilization (IVF).  
The transfer of seemingly good-quality embryos can often result in a negative pregnancy 
outcome.  There are many factors that can contribute to implantation potential, including 
embryo aneuploidy, advanced maternal age, and sperm and oocyte quality among many others.  
However, little is understood regarding the molecular mechanisms responsible for embryo 
development during the window of implantation. 
Therefore, the overall aim of this thesis was to understand the biological and epigenetic 
mechanisms during embryo implantation development by specifically investigating: 
(1)  How both maternal age and/or chromosome constitution affect microRNA profiles and 
downstream target RNAs of pre-implantation blastocysts, (2) the hypothesis that advanced 
maternal age is impacting the overall transcriptome of the developing embryo, (3) if methylation 
alterations are present in aneuploid  blastocysts and if this contributes to implantation potential, 
(4) how different types of infertility diagnoses are impacting the transcriptome of the pre-
implantation blastocyst, and (5) if it is possible to detect polymorphisms in patients with 
premature diminished ovarian reserve and if methylation alterations are found in the germline 
of embryos from this infertile population which affect implantation potential. 
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The conclusions of these aims are as follows: 
Both chromosome constitution, as well as advanced maternal age, affect miRNA profiles of the 
developing blastocyst.  MiR-93 was found to be exclusively expressed in women of advanced 
maternal age and further up-regulated in aneuploid embryos.  The increased expression of this 
miRNA was additionally found to result in a down-regulation of SIRT1, its target gene, which likely 
affects the oxidative stress defense mechanisms of the embryo, thereby reducing implantation 
potential.  Additionally, an overall decreased global transcriptome was observed in maternally 
aged blastocysts, impacting biological pathways involved in cell growth and invasion which are 
vital to pre-implantation embryo development. 
Epigenetic alterations were also observed in aneuploid blastocysts.  A hypomethylated state was 
revealed but only in monosomic embryos and only in the chromosome involved in the error.  
Decreased expression of developmental genes located on the chromosome of error were also 
observed.  In contrast, the trisomic blastocyst displayed transcriptional dosage compensatory 
mechanisms for the presence of the additional chromosome.  This might partially explain the 
difference in implantation potential between trisomic and monosomic embryos. 
Underlying infertility diagnosis was also found to have a significant impact on the blastocyst 
transcriptome.  Alterations were observed for all infertility etiologies examined.  Biological and 
molecular processes of the altered transcriptomes revealed both similarities, as well as 
differences, across the groups.  Similarities included alterations to reproductive genes, cell 
adhesion, and response to stimulus genes among others.  These processes are characterized by 
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cells that are able to proliferate, migrate, and attach and are all crucial to embryo development 
and implantation.   
Lastly, young women with premature diminished ovarian reserve (DOR) were found to have 
critical variants in DNA sequence.  Utilizing exome sequencing, a panel of single-nucleotide 
polymorphisms (SNPs) was able to distinguish DOR women <32 years old from age-matched 
controls.  Additionally, this study was able to determine that despite these SNP variations, no 
downstream alterations to biological processes are affecting the resulting blastocyst. 
Data presented in this thesis shows an overall compromised biological state for embryos 
produced from couples with different infertility diagnoses, as well as aneuploid embryos which 
are known to have a lower implantation potential.  The exception appears to be that women with 
premature DOR can produce competent oocytes that are not being impacted due to premature 
ovarian aging and therefore likely have a higher potential for reproductive success. 
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10.0 Introduction 
10.1. Overview of Infertility  
Infertility affects up to 25% of reproductive-aged couples and is diagnosed when a couple fails to 
achieve pregnancy after 12 months of regular, unprotected intercourse [1].  There are many 
different causes of infertility, both on the male and female side.  Female factor infertility can 
include tubal blockage, problems with ovulation, insufficient ovarian reserve, endometrium 
insufficiencies, hormonal imbalances, recurrent pregnancy loss, and advanced age among others 
[2].  Male factor infertility can be caused by anything ranging from genetic mutations to lifestyle 
choices but is often the result of poor semen parameters (count, morphology, and motility) [3].  
Male factor infertility accounts for 20-30% of human infertility and contributes to half of the 
overall infertility seen in patients presenting for ART [4].  When all known sources of infertility 
have been ruled out, a couple is defined as idiopathic or unexplained, which affects anywhere 
from 15-30% of all infertile couples [5]. 
10.1.1. Polycystic Ovaries 
Women with polycystic ovaries (PCO) have an abnormally high density of partially mature follicles 
but can possess normal hormone balances and regular ovulation.  However, these patients often 
struggle with infertility due to anovulation and decreased fertilization after IVF due to poor 
quality oocytes [6].  PCO affects anywhere from 20-30% of the population and the causes are 
largely unknown [7].  Women with polycystic ovarian syndrome (PCOS) not only have the 
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increased immature follicle counts, but also possess hormonal imbalances, typically excess 
androgen production, which lead to rare or irregular ovulation [8].  PCOS is the most common 
endocrine disorder in women of reproductive age and is a major cause of female factor infertility 
[9].  These patients often require ART to conceive and have poorer quality oocytes and embryos 
[6]. 
10.1.2. Endometriosis 
Endometriosis affects 5-10% of the general female population and 20-30% of women diagnosed 
with infertility [10].  It is defined by the presence of endometrial-like tissue outside of the uterus 
which induces an inflammatory reaction and can alter endometrial function [11].  Women with 
endometriosis have an increased volume of peritoneal fluid with high concentrations of 
macrophages, prostaglandins, and proteases which can adversely affect not only the oocyte but 
also the sperm and embryo resulting in impaired receptivity and embryo implantation [12].  
10.1.3. Diminished Ovarian Reserve 
Ovarian reserve describes the capacity of the ovary to provide oocytes for reproduction.  Females 
are born with their lifetime supply of oocytes which continuously decline every month until 
critically low levels are reached and this is when menopause ensues [13].  The age at menopause 
can vary significantly between women and is likely more sensitive to the rate of follicle atresia 
than the actual number of oocytes remaining [14].  Diminished ovarian reserve is characterized 
by a reduction in the quantity and/or quality of eggs remaining in a woman’s ovaries and is 
common as women age and reach their fifth decade of life [15, 16].  Anti-Müllerian Hormone 
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(AMH) is an endocrine marker often used to assess ovarian reserve [17].  It is produced by 
granulosa cells of the ovary and its release leads to measurable serum levels that are proportional 
to the number of developing follicles [18].  This allows for the ability to predict not only the 
number of follicles present in the ovaries, but also ovarian response to hyperstimulation [18].  
Diminished ovarian reserve is associated with female infertility as well as poor response to 
ovarian stimulation and approximately 10% of women will experience premature DOR causing 
infertility at a young age [19]. 
10.1.4. Male Factor Infertility 
Testicular function is largely controlled by both gene expression and repression via the Sertoli 
cells [20].  These cells are not only responsible for nourishing the developing germ cells but are 
the location for spermatogenesis.  The total number of Sertoli cells present correlates with the 
overall level of sperm production [21] and any defects during mitotic division of spermatogonia 
can have negative consequences to male fertility [22].  Types of male factor infertility can include 
structural abnormalities in the reproductive tract (congenital or caused by infection), sperm 
production deficiencies (vasectomy or varicocele), ejaculatory disorders, or immunologic 
disorders (endocrine or antisperm antibodies) [23].  Many factors such as genetic, hormonal, 
environmental and even physical can affect sperm production.  These can lead to sperm disorders 
including azoospermia, oligospermia, asthenozoospermia, and teratozoospermia which can 
affect the production, maturation, shape, and motility of sperm.  Azoospermia is defined as a 
total absence of measurable sperm in an ejaculate while oligospermia is low sperm count (<15 
million/mL) [24].  Asthenozoospermia is a term used to describe sperm motility of <40% and 
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teratozoospermia is a condition characterized by a reduced percentage (<4%) of sperm with 
normal morphology [25]. 
10.2. Gametogenesis 
Gametogenesis is the process in which cells undergo a series of mitotic and meiotic division to 
produce mature haploid gametes.  These mature gametes can then undergo fertilization to 
produce a zygote [26].  First, primordial germ cells are arrested at the G2 phase of the cell cycle 
and later migrate into the genital ridge to aid in the formation of the embryonic gonad [27, 28].  
These cells then differentiate to become spermatogonia or oocytes [29]. 
10.2.1. Spermatogenesis 
Spermatogenesis is defined as the production of sperm from primordial germ cells [30].  
Spermatogonia in the seminiferous tubules first divide by mitosis and then form primary 
spermatocytes through meiosis [31].  Primary spermatocytes then divide meiotically into 
secondary spermatocytes which complete meiosis to create haploid spermatids [31].  The 
spermatids undergo spermiogenesis to become mature spermatozoa with highly packaged 
chromatin that are released into the lumen of the seminiferous tubule (Figure 10.1) [31, 32].  
During spermatid development, the paternal genome undergoes a reorganization and is then 
packaged into the nuclei of the spermatozoa [33].  Chromatin remodeling plays a critical role 
during spermatogenesis, replacing histones with DNA packaging proteins, and later protamines, 
to allow for DNA compaction which prepares the germ cells for fertilization [34] and could also 
contribute to the regulation of post-fertilization transcription [35].  Mature sperm are highly 
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methylated through the actions of DNMTs and this methylation is maintained through early 
embryo development [36, 37].  DNA methylation patterns during spermatogenesis set up 
paternal imprints which are maintained until being re-established in the germ line [38].  Both de 
novo methylation and demethylation occur during the early phases of spermatogenesis and are 
completed by the end of the pachytene stage [39].  DNMT3a and 3b are highly expressed in 
spermatogonia and are likely the facilitators of methylation in early germ cells. 
10.2.2. Oogenesis  
Oogonia form primary oocytes after the first meiotic division where they continue to develop 
until the diplotene stage and are then arrested in development until the onset of puberty [30].  
This is also the time when DNA methylation is re-established after pre-existing epigenetic marks 
have been erased [40].  Meiosis is then resumed after ovulation to form the secondary oocyte 
and polar body (Figure 10.1).  Unlike sperm, the female gamete has an enriched histone-
containing cytoplasm that is essential to fertilization and development.  In mouse oocytes, 
chromatin is initially decondensed and progressively re-condenses before meiotic maturation 
[41].  DNMT3A and DNMT3L are both required for de novo methylation of the gDMR (germline 
differentially methylated region) in oocytes [42].  DNMT3L is also critical to the establishment of 
maternal imprints during this time [38, 43]. DNA methylation patterns of imprinted genes must 
be accurately established and maintained despite genome-wide changes during the time of pre-
implantation [44].  H19 and IGF2R are examples of maternally expressed imprinted genes and 
disruptions to the imprinting process during oogenesis lead to altered imprinted gene expression 
during embryogenesis [45] and can result in imprinting disorders including Beckwith-Wiedemann 
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and Angelman syndromes [46].  DNA methylation of imprinted genes occurs while oocytes are 
maturing during meiotic prophase I, through the recognition of imprinted loci by DNMT3A and 
DMNT3L [42, 47].  In mouse oocytes, histones H3 and H4 become deacetylated at the MI stage 
and it is thought that inadequate deacetylation of histones in aged oocytes plays a role in the 
increased incidence of aneuploidy [47].  H3 and H4, however, seem to be the only histones that 
are modified during meiosis [47].  Once ovulation has occurred and the oocyte has become 
fertilized, MII is completed.  The oocyte contributes not only the maternal genome to the 
resulting zygote, but also epigenetic factors required for reprogramming after fertilization [47]. 
 
Figure 10.1: Oogenesis and Spermatogenesis:  Oogonium give rise to primary oocytes which 
become primordial follicles that mature after puberty.  Prior to ovulation and after meiosis I, a 
secondary oocyte is created with a non-viable polar body.  During ovulation the secondary oocyte 
is released from the ovary and completes meiosis II once it has been fertilized.  Spermatogonia 
divide by mitosis and become spermatocytes.  Meiotic division forms spermatids which then 
differentiate into sperm that fertilize the oocyte. 
Biological Mechanisms Impacting Pre-Implantation Embryo Development 
25 
10.2.3. Pre- and Post-Fertilization and Embryonic Development 
PGCs are first created in the embryo at day 6.5 of development and do not mature until they 
reach the gonad [48].  It is during this time that genome-wide erasure and reprogramming is 
initiated in the PGCs to remove old imprint marks and establish new parent-of-origin-specific 
imprints, determined by the sex of the developing embryo [49-51].  A demethylated state 
remains until mitotic/meiotic arrest in male/female germ cells [51].  De novo methylation begins 
in sperm once mitotic divisions have resumed and is concluded by meiosis I [51].  In oocytes 
however, de novo DNA methylation does not begin until maturation and ends by metaphase II 
[51].  Once a spermatozoon has fertilized an oocyte, haploid sets of chromosomes from each are 
decondensed, forming paternal and maternal pronuclei [52].  De novo methylation then 
transcriptionally activates these pronuclei resulting in DNA replication which segregates the DNA 
to daughter cells and allows chromosomal recombination to occur [53].  The second wave of 
reprogramming occurs during this time where the paternal pronucleus undergoes rapid 
demethylation with the maternal genetic material not being demethylated until the cleavage 
stage and finally equalized with the paternal genome by the morula stage [49-51].  This erases 
the methylation marks of non-imprinted genes [48] before methylation is re-established in the 
morula and continues in the inner cell mass (ICM) with the trophectoderm (TE) remaining 
relatively hypomethylated [54].  The methylation asymmetry continues throughout gestation 
with the fetus having high levels of methylation compared to the placenta (Figure 10.2) [54].  
Epigenetic changes in XIST RNA are also important during embryo development and occur on the 
X chromosome in female embryos [48].  This allows one of the X chromosomes to become 
transcriptionally repressed so that the expression of genes within the X chromosome are equal 
Biological Mechanisms Impacting Pre-Implantation Embryo Development 
26 
to that of male embryos [48].  Santos et al. confirmed that the cycle of methylation 
reprogramming occurs in the ICM and not the TE, meaning that de novo methylation is 
responsible for this reprogramming during pre-implantation development [55].  The placenta, 
which protects the fetus and allows for the exchange of waste and nutrients to and from the 
mother is crucial to embryo development [56].  Despite the hypomethylated state of the 
trophoblast, DNA methylation is necessary for the invasive behavior of these cells which is 
required for implantation [57]. 
 
Figure 10.2: DNA methylation levels during embryo development:  Highly methylated PGCs 
undergo global demethylation before gametes are re-methylated in a sex-specific manner.  After 
fertilization, methylation of the male and female genomes are differentially erased while 
imprinted genes remain methylated.  Methylation is then re-established after the blastocyst 
stage of development.  Image adapted from Smallwood (2012). 
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10.3. Imprinting 
Normal mammalian development requires genetic material from both the egg and the sperm.  
The maternal genome plays an important role in fetal development while the paternal genome 
is typically more important for placental development [58].  Genomic imprinting refers to a 
phenomenon where one parental allele is silenced during the late stages of gametogenesis 
resulting in a monoallelic, parent-of-origin specific gene expression [54].  Each step during this 
process requires epigenetic marks of the ICR and maintenance of the imprinted state through 
replication [59].  Imprinting is best established through differential DNA methylation as imprinted 
genes are protected from the global demethylation that occurs during development to preserve 
these parental imprints (Figure 10.3) [60, 61].   
 
Figure 10.3:  Genomic imprinting:  Parental DNA methylation is erased in primordial germ cells 
to establish sex-specific imprints during gametogenesis.  This results in parent-of-origin 
expression of imprinted genes. 
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Later on in germ cell development these genomic imprints are erased and newly established 
during the process of gametogenesis [61]. To date, over 1,000 imprinted genes have been 
discovered in the mammalian genome, many of which are involved in fetal growth and 
development [62].  Since imprinted genes are subject to more complex regulation, there are 
more opportunities for epigenetic errors to occur [49].  These errors can result in imprinting 
disorders through improper gene expression caused by mutations, methylation defects, or 
uniparental disomy (UPD) [63].   UPD is the result of both homologues of a chromosomal region 
being inherited from one parent.  Various clinical outcomes are observed depending on the 
chromosome where the UPD occurs.  In some instances, there is no adverse effect but if the UPD 
occurs in an imprinted gene region then the cells will either inherit two active, or two silent alleles 
[64].   The resulting imprinting disorders include Prader-Willi syndrome, Angelman syndrome, 
and Beckwith-Weidemann syndrome [65, 66].  Chromosome rearrangements, such as deletions, 
duplications, and translocations can also cause imprinting disorders [67].  Deletions can occur 
during errors in cell division and the effects differ depending on the size and location of the 
deleted sequence [68].  Larger deletions typically result in more severe phenotypes due to the 
number of genes affected and the resulting effect on gene dosage [68].  Deletions of the 
imprinted UBE3A gene, for instance, are known to result in a more serious form of Angelman 
syndrome [69].  Translocations occur when a segment from one chromosome is transferred to a 
non-homologous chromosome or to a new site on the existing chromosome [70].  They can be 
balanced, unbalanced, reciprocal, or robertsonian.  Reciprocal translocations are most common 
and can occur between any two chromosomes [71].  Genetic material is swapped from one 
chromosome to the other (Figure 10.4a).  Robertsonian translocations involve exchanges only 
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between chromosomes 13, 14, 15, 21, and 22 [72].  Since these chromosomes have their 
centromeres near the tip of the chromosome, they have a long arm and short arm.  These types 
of translocations result in the loss of both short arms and a fusion of the remaining long arms 
(Figure 10.4b) [73]. 
 
Figure 10.4: Methods of Chromosomal Translocation.  (a) Reciprocal Translocation:  A break in 
two chromosomes with an exchange of the broken segments. Image adapted from National 
Human Genome Research Institute.  (b) Robertsonian Translocation:  A break in two acrocentric 
chromosomes resulting in the loss of their short arms and fusion of the long arms. 
10.4. Overview of Epigenetics 
The concept of epigenetics was first introduced nearly 80 years ago by Conrad Hal Waddington 
and was very broad in its scope, simply referring to events that lead to genetic programming for 
development [74].  Discoveries in the role of DNA in inheritance and chromatin structure have 
redefined epigenetics as heritable changes in gene expression that occur without altering the 
underlying DNA sequence [75].  Epigenetic marks on DNA can result in either the silencing of a 
gene or can make it accessible for transcription.  These marks are the result of histone 
modifications or methylation of DNA and result in alterations of not only individual gene 
expression but also regulation of the entire developmental landscape [76].  Epigenetic 
a b 
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inheritance is essential for normal mammalian development and is particularly important during 
the early stages of germ cell differentiation [35]. It is mostly stable during development, with 
changes only occurring during periods of genome-wide reprogramming such as in primordial 
germ cells (PGCs) and the pre-implantation embryo [50].  
10.4.1. DNA Methylation 
Certain regions of genes such as promoters, enhancers, and silencers contain a cytosine 
nucleotide alternating with guanine nucleotide (CpG) [77].  CpG sites are typically grouped in 
clusters, called CpG islands, and are found within stretches of DNA that have high frequencies of 
C-G dinucleotide repeats in the 5’ regulatory regions of most genes [78].  DNA methylation 
involves the transfer of a methyl group to the cytosine of a CpG dinucleotide without altering the 
underlying DNA sequence [79].  Methylation of CpG islands leaves an epigenetic mark that 
defines a set of gene activity instructions for the cell and usually results in transcriptional 
repression of that gene [79].  This is achieved by methyl-CpG-binding proteins (MBPs) which act 
to prevent transcription factors from binding to promoter sequences and can also recruit histone 
modifying enzymes that alter nearby chromatin resulting in compaction [80].  The conversion of 
methyl-cytosine into cytosine during DNA demethylation can be either active or repressive [81].  
TET enzymes are involved in active demethylation whereas passive demethylation is replication-
dependent and occurs because of a failure of maintenance methylation [81, 82].  The 
hypermethylation of a promoter region will result in gene silencing while demethylation will 
promote expression [81, 83, 84]. 
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DNA methylation is established by the activities of DNA methyltransferase enzymes (DNMTs) 
including DNMT1, DNMT2, DNMT3A, DNMT3B, DNMT3C, and DNMT3L.  DNMT1 is the 
maintenance methyltransferase which copies correct methylation patterns to daughter strands 
during replication [85].  DNMT2 has been shown to regulate small RNAs rather than DNA, 
specifically aspartic acid transfer RNA [86].  DNMT3A and 3B establish methylation marks de novo 
by placing the methyl group on a DNA sequence during embryonic development [85].  DNMT3C 
is a duplication of DNMT3B and silences young transposons in the male germ cell, preserving 
male fertility [87].  DNMT3L does not have much enzymatic activity but works to stimulate 
DNMT3A and 3B which are required for the establishment of maternal imprints in oocytes [43].  
Proper methylation is critical during cell differentiation and early embryo development to allow 
daughter cells to become different cell types within the organism [88].  In mice, the loss of Dnmt1 
results in embryonic lethality [89].  Similarly, targeted disruption of Dnmt3a and/or Dmnt3b also 
cause embryonic lethality in the mouse model [90]. 
DNA is wrapped around histone proteins which can add chemical groups to make it more or less 
compact.  In the case of the oocyte, DNA is tightly coiled allowing it to be compressed into a cell 
nucleus which makes the regulatory sites inaccessible to transcription and therefore silenced.  In 
sperm, the DNA associated proteins are made up of mostly protamines, which also make the DNA 
transcriptionally inactive [91].  The levels of global methylation vary greatly between sperm and 
oocytes.  The sperm genome is nearly 90% methylated whereas mature oocytes are only 40% 
methylated [92].  DNA methylation in the oocyte is also a gradual process, increasing as the 
oocyte grows in size during the later stages of follicular development [93].  Early during 
development, genome-wide changes occur in methylation patterns which allow for the 
Biological Mechanisms Impacting Pre-Implantation Embryo Development 
32 
maintenance of specific transcriptional sites necessary for pluripotency [94].  The embryo itself 
undergoes global demethylation until the zygote stage where methylation is thought to occur 
both actively and passively resulting in an asymmetry between the paternal and maternal 
genomes [95].  The overall DNA methylation levels decrease as the embryo continues to develop 
until the blastocyst stage, which displays the lowest level of methylation than that of any other 
time point (Figure 10.5) [55].  DNA methylation is important in the regulation of such processes 
as chromosome stability, imprinting, and X chromosome inactivation and functions to silence 
large portions of ‘junk’ DNA repeat sequences, as well as incorrect expression of genes [38, 96].  
DNMT1, DNMT3A, and DNMT3B are particularly important as the absence of any one of these 
genes has been determined to be lethal in mice [97].  
 
Figure 10.5: Epigenetic regulation during mammalian development.  Expression of key 
developmental genes and epigenetic modifications increase from light to dark in each bar.  DNA 
methylation is erased during early embryonic development while histone methylation and 
pluripotency-associated gene expression begin increasing. Image adapted from Reik (2007). 
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10.4.2. Chromatin Modifications 
Post-translational modifications of histones are another type of epigenetic regulation.  Four 
histones - H2A, H2B, H3, and H4 - make up the basic structural unit of chromatin that form 
compact octamers which are wrapped with DNA to provide stability [98].  These histones contain 
N-terminal tails which protrude from the surface of the nucleosome and this is where 
modifications primarily occur which include acetylation, methylation, phosphorylation, and 
ubiquitination (Figure 10.6) [99]. Changes to these histones lead to alterations in chromatin 
structure and compaction.  During mammalian development, certain histone modifications can 
influence DNA methylation patterns, and likewise, DNA methylation can establish histone 
modifications [100].  Depending on the chromatin state, rapid changes in gene expression during 
early development can occur and be either repressive or activating.  Regions of the genome that 
are less compact and contain more active genes are known as euchromatin, whereas the more 
condensed regions, such as centromeres and telomeres, contain mostly inactive genes and are 
known as heterochromatin [101].  Post-translational modifications, known as histone marks, 
occur at histone tails.  These marks can result in either gene transcription or gene silencing 
depending on the modification [102].   
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Figure 10.6: Histone tails with modifications including methylation, acetylation, ubiquitination, 
and phosphorylation. 
Acetylation occurs at lysine residues and is initiated by histone acetyltransferases [98] which 
remove the positive charges, reducing the affinity between histones and DNA.  This allows 
transcription factors to have easier access to the promoter region thereby having a stimulatory 
effect on transcription which can then be reversed by histone deacetylases through the 
repression of transcription to silence gene expression [100].  Histone acetylation plays a role in 
processes that regulate the structure and function of chromatin.  Acetyltransferase HBO1 has 
been shown to be an essential activator of genes required for normal embryonic development 
[103].  Histone deacetylases have been shown to be important regulators of apoptosis, cell 
proliferation, and the cell cycle [104].  Additionally, HDAC1 has been found to be critical for the 
hyperacetylated state of histones in the pre-implantation embryo [105].   
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Methylation of histones occur on lysine and arginine residues which result in either gene 
activation or repression [106].  There are three methylation sites implicated in active translation 
(H3K4, H3K36, and H3K79) and three linked to transcriptional repression (H3K9, H3K27, and 
H4K20) [107].  Histone methylation has been associated with proper regulation of gene 
expression and other important biological processes including stem cell maintenance, cell cycle 
regulation, and X chromosome inactivation [108].  Methylation of H3K4 is probably the most well 
understood and occurs in three different states:     mono-, di, or tri-methylation.  Active 
promoters are marked by trimethylation and dimethylation is often found in promoter regions 
[109].  H3K4 methylation is thought to be involved in maintaining transcription rather than 
initiating it [110].  Varying degrees of H3K4 methylation are found on many genes during 
embryonic development and regulation of H3K4 methylation is essential during cell 
differentiation [111]. 
Phosphorylation can occur on serine, threonine, or tyrosine residues.  Histone phosphorylation 
is involved in DNA damage repair and can regulate transcription [112].  It is predominantly 
involved in cellular processes associated with chromatin remodeling and gene expression.  ATP 
is a common method for controlling gene expression by regulating post-translational 
phosphorylation of transcription factors.  One example of this is the p53 pathway.  p53 is a tumor 
suppressor that both activates and inhibits many genes in its pathway.  If a cell is damaged, p53 
can actively transcribe genes that then lead to cell death.  Stress signals in the cell will activate 
protein kinases causing phosphorylation which result in p53 activation [113].  Phosphorylation of 
histone H3 has also been shown to be a marker for chromosomal condensation and cell cycle 
progression during mitosis and meiosis [114]. 
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Ubiquitin is a 76-amino acid protein and is involved in a variety of cellular responses including 
stress response, protein degradation, and transcriptional regulation [115].  H2A and H2B are the 
most common proteins ubiquitinated and predominantly result in gene activation.  However, 
ubiquitination can also result in gene silencing depending on what region the modification takes 
place.  Histone ubiquitination is induced by DNA damage and plays an important role in DNA 
damage response [116].  Monoubiquitination of H2A occurs on the inactive X chromosome in 
females whereas monoubiquitination of H2B is involved with chromatin function and integrity 
[116].  Histone ubiquitination and deubiquitination are also essential for stem cell maintenance 
and differentiation [116]. 
10.4.3. Non-coding RNAs 
Non-coding RNAs (ncRNAs) are functional RNA molecules that are transcribed from DNA but do 
not get translated into proteins and are required for regulation of gene expression.  They also 
regulate the expression of genes in cis- and trans- and are involved in genomic imprinting and X-
chromosome inactivation [117].  They include small interfering RNAs (siRNAs) and microRNAs 
(miRNAs) and can regulate expression via transcription, translation, mRNA degradation, or 
splicing [118].  These short, non-coding RNAs also play an important role in DNA methylation 
targeting, heterochromatin formation, and histone modification [119].   
MicroRNAs are endogenous, small, single-stranded, non-coding RNA molecules that regulate 
gene expression via translational repression of target mRNAs [120, 121].  While the mechanisms 
behind this are not entirely understood, it is known that microRNAs are produced from stem-
loop structures and are processed in the nucleus by RNase III Drosha and the RNA binding protein 
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DGCR8 [122].  These pre-microRNAs are then exported to the cytoplasm and undergo additional 
processing by RNase III Dicer which binds the microRNA to Argonaute proteins forming the core 
of the RNA-induced silencing complex (RISC) (Figure 10.7) [123, 124].  There are a variety of ways 
in which RISC-mediated down-regulation can occur including mRNA cleavage that leads to decay 
as a result of perfect base pairing of the microRNA to its target gene, deadenylation which occurs 
due to partial base pairing to target sites, and translational repression [123, 125].  Recent 
evidence has also suggested that certain microRNAs can up-regulate gene expression [125-129] 
or relieve repression [130, 131].  Up-regulation is achieved through activation by micro-
ribonucleoproteins (miRNPs) and relief occurs indirectly through microRNA-mediated 
suppression of miRNPs that would normally repress target gene expression [132].  MicroRNAs 
have a variety of functions during development including pluripotency in the embryo [133], 
placental formation in mice [134], and embryo implantation [135].  Regulation of RNA is also 
responsible for X chromosome inactivation through the expression of the XIST gene which 
recruits chromatin-remodeling proteins to block transcription [136]. 
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Figure 10.7: MicroRNAs are processed by Drosha and DGCR8 before being exported to the 
cytoplasm where Dicer and TRBP bind Argonaute proteins forming the RISC complex which 
regulates mRNA expression.  Image adapted from Kai and Pasquinelli (2010). 
siRNAs were originally observed in virus-induced silencing, thought to be involved in genome 
defense [137].  Since then, trans-acting siRNAs that regulate very specific target genes have been 
discovered as well as an abundance detected in centromeres, transposons, and other repetitive 
sequences [138, 139].  Therefore, not only do siRNAs originate from foreign bodies, they also 
arise from endogenous sources [140].  They operate similarly to miRNAs to mediate post- 
transcriptional gene silencing but can also induce heterochromatin formation by promoting 
methylation and chromatin condensation [140] (Figure 10.8). 
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Figure 10.8: Mechanisms of siRNA silencing:  Double-stranded RNA binds with DICER to generate 
siRNA duplexes.  The guide RNA then binds with Argonaute to form the RISC complex which binds 
to the complementary sequence of the target mRNA resulting in the inhibition of translation.  
Image adapted from Majumdar (2017). 
10.4.4. Long Non-coding RNAs 
The majority of the mammalian genome is transcribed, generating long non-coding RNAs 
(lncRNAs) which are defined as being longer than 200 nucleotides and not translated into protein 
[141, 142].  These RNAs are further sub-divided depending on their location in the genome:  
intergenic and intragenic; and can be cis- or trans-acting to induce transcriptional activity [143].  
While most lncRNAs are non-functional, others such as nuclear lncRNAs are involved in various 
biological processes including gene regulation and chromatin accessibility [141].  Cytoplasmic 
lncRNAs, on the other hand, are limited to post-transcriptional and translational regulation as 
well as mRNA stability [144].  LncRNAs can also act as scaffolds to modulate transcription [145].  
During early embryonic development, lncRNAs are involved in X chromosome inactivation, where 
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the inactive XIST transcript is transcribed only from the inactive X chromosome which results in 
gene silencing [146]. 
10.5. Aneuploidy 
A normal human cell contains 23 pairs of chromosomes for a total of 46.  Aneuploidy refers to 
one or more missing (monosomy) or extra (trisomy) chromosomes and is the cause of genetic 
conditions such as Down syndrome (trisomy 21).  40-50% of oocytes from women aged 35-39 will 
have chromosomal aneuploidies (Figure 10.9).  This can climb to over 70% by the time a woman 
reaches 45 years of age [147].  This age-related decline in fertility includes reduced ovarian 
reserve, poor oocyte quality, and uterine insufficiencies, all of which contribute to the ability of 
an embryo to correctly implant and become a viable pregnancy [148, 149].  Many meiotic 
abnormalities related to maternal age can lead to compromised embryo viability including the 
inability to complete oocyte maturation or errors during maturation [150].  Cytoplasmic factors 
that regulate the cell cycle can also contribute to oocyte incompetency.  Spindle assembly has 
been shown to be altered in older women leading to chromosome misalignment which explains 
the high incidence of aneuploid embryos observed in women of advanced maternal age [151].  
Oxidative stress in aged oocytes has also been shown to disrupt mitochondrial function leading 
to decreased oocyte competency and embryo quality [152].  Oocyte deficiencies are considered 
the most common cause of infertility in advanced age due to the fact that much higher success 
rates are observed in donor oocyte programs in IVF clinics around the world compared to when 
older women use their own oocytes. 
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Figure 10.9: Significant increase in the number of aneuploid blastocysts as a woman ages. 
Schoolcraft & Katz-Jaffe, 2013; Katz-Jaffe et al. ASRM 2015. 
There are a number of trisomies that not only implant, but result in live birth.  These include 
trisomies of the sex chromosomes, 13, 18, and 21.  Other trisomies implant but typically result in 
miscarriage and include chromosomes 15, 16, and 22 (46).  In contrast, there is only one full 
monosomy seen in clinical pregnancy, chromosome X.  All other full autosomal monosomies are 
lethal.  With an increasing number of advanced maternal age women (AMA, >35 years) looking 
to conceive, PGT techniques are offered to minimize the risk of reproductive failure.  
10.5.1. Mechanisms of Aneuploidy 
Errors in chromosome segregation lead to aneuploidy [153] and mis-segregation during meiosis 
is the primary cause of aneuploidy for infertile patients which is responsible for ~1/3 of all 
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miscarriages [154].  The majority of these chromosome errors are derived from the oocyte which 
is responsible for up to 90% of the aneuploidies, depending on the age of the woman [155].  This 
is in stark contrast to spermatozoa which are only afflicted at a rate of 2-10% [156].   
In the oocyte, meiosis occurs to separate homologous chromosomes and produce sister 
chromatids [157].  Accurate chromosome segregation during meiosis I relies on the orientation 
of the spindle microtubules which must be in a bipolar configuration so that the two sister 
chromatids face the same spindle pole [153, 157].  These microtubules attach to chromosomes 
via kinetochores and checkpoint signaling prevents sister chromatid separation until the proper 
number of microtubules have been bound [153].  Once this has happened, cytokinesis is 
responsible for cell division, resulting in two daughter cells each with a normal chromosome 
constitution (Figure 10.10) [153].  Segregation errors can occur at any point during meiosis and 
differ depending on the chromosome involved in the error but both meiosis I and meiosis II 
produce the majority of aneuploidy in zygotes equally [158, 159]. 
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Figure 10.10: Different mechanisms for chromosome segregation.  (a) Sister kinetochores attach 
to microtubules from opposite spindle poles.  This is the proper bi-orientation chromosome 
segregation and is known as amphitelic attachment.  (b) Chromosome mis-segregation from 
sister kinetochores attached to microtubules from the same spindle pole is syntelic attachment.  
(c)  Monotelic attachment is when only one of the kinetochores is attached.  (d) Chromosomes 
showing merotelic attachment have sister kinetochores attached to both poles.  Image adapted 
from Yamagishi (2014). 
10.5.2. Epigenetic Origins of Aneuploidy 
Improper chromosome segregation resulting from various defects such as mitotic spindle 
alterations and cell-cycle checkpoint malfunctions have been associated with the onset of 
aneuploidy [160].  These can be induced by mutations in genes that control chromosome 
segregation and failures in both DNA damage response and double-strand break repair.  The 
function of the spindle checkpoint system is to ensure that all chromosomes are correctly aligned 
and attached to the mitotic spindle prior to chromosome separation.  Defects in this system have 
been shown to result in not only chromosome instability, but also various types of cancers.  DNA 
methylation also plays an important role in aneuploidy since cells with reduced methylation 
a b c d 
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appear to be more susceptible to undergoing chromosomal gains and losses (44).  Epigenetic 
marks can be modified by many factors including both genetic and environmental which can lead 
to chromosome instability and aneuploidy.  With regard to the oocyte, there is a particular 
susceptibility to aneuploidy during the two meiotic cell divisions which is amplified with 
advancing maternal age.  This is thought to be caused through sister chromatid cohesion that 
hold the chromosomes together weakening over time [161].  Likewise, advanced maternal age 
can also have an effect on epigenetic modifications in the oocyte due to altered expression of 
DNMTs and histone acetyltransferases [162]. 
10.6. Genetics and Infertility 
Improper DNA methylation can result in various diseases including infertility [163, 164].  In the 
male, this primarily occurs within the sperm genome [165].  Epigenetic modifications regulate 
germ cell development during spermatogenesis and incorrect imprinting is associated with male 
infertility [166, 167].  For instance, hypomethylation of the imprinted gene H19 along with the 
hypermethylation of MEST is associated with oligospermia [81, 168].  However, this is less 
common in females as most of the imprinted genes have already been epigenetically modified 
by oogenesis [81].  For the fertilized oocyte to properly develop however, imprinted DNA 
methylation patterns have to be correct during oocyte growth and maturation [81]. 
Histone modifications also play a role in infertility.  Modifications to H3K4, H3K9, and H3K27 have 
all shown to be critical for spermiogenesis and deviations can lead to male infertility [169, 170].  
Likewise, improper histone modifications during oocyte reprogramming can result in decreased 
oocyte development and even death [171, 172].  The histone variant H3.3 is particularly 
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important during oocyte reprogramming as it is required for chromosome structure and can lead 
to aneuploidy if deacetylation is inhibited [105].  Disruptions to H3K9 have also been shown to 
reduce ovulation, oocyte fertilization, and embryo implantation [173]. 
ncRNAs are essential for spermatogenesis and aberrant expression can result in sperm apoptosis 
and male infertility [174, 175].  The presence of a single nucleotide polymorphism at a miRNA 
binding site of its target RNA is involved in idiopathic male infertility [176].  A SNP is defined as a 
variation at a single position in a sequence if it occurs in less than 1% of the population [177].  
These variations are mostly biallelic and can occur in coding regions of a gene, non-coding 
regions, or intergenic regions.  They are considered the most common form of genetic variation 
and are largely associated with human disease [178].  SNPs have been analyzed over the last 
decade to study various reproductive issues such as reproductive lifespan in women, 
endometriosis, PCOS, uterine fibroids, ovarian reserve, and male factor infertility [179-190].  A 
recent study identified infertility-causing human mutations using a mouse model for genome 
editing [191].  Another study looked at FMR1 CGG repeats in infertile women and found 
epigenetic marks in the regulatory regions resulting in increased FMR1 gene expression in the 
blood and granulosa cells of DOR patients with the premutation [192].  SNPs are also routinely 
analyzed to detect inherited diseases in pre-implantation embryos including cancer, 
translocations, and microdeletions and duplications [193].  Copy number variations (CNVs) are 
equally important and involve alterations in the number of copies of a DNA region which can 
comprise either deletions or duplications [194].  These alterations can be sporadic or inherited 
and are associated with human disease [195].  Genetic defects, including CNVs, are considered 
to be one of the leading causes of male infertility [196].  This is largely due to the fact that the Y 
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chromosome is particularly prone to such alterations due to the high proportion of segmental 
duplications which allow for the generation of CNVs [197]. 
10.7. Assisted Reproductive Technologies  
The Centers for Disease Control and Prevention (CDC) define ART as any fertility treatment that 
involves both an oocyte and sperm and include in vitro fertilization, intracytoplasmic sperm 
injection (ICSI), and pre-implantation genetic testing (PGT).  IVF involves maturing the follicle and 
stimulating oocyte development with the use of various combinations of hormones [198].  After 
egg retrieval takes place, the oocyte is fertilized using one of two different techniques [199].  The 
first technique is ICSI where one sperm is injected into the cytoplasm of one egg; while the second 
method is through conventional IVF where sperm compete to fertilize an egg [200].  Normally 
fertilized early embryos are then cultured under optimized in vitro conditions for 2-7 days and 
can be screened for chromosome numeration by either biopsy of a blastomere from a day 3 
embryo or 4-8 trophectoderm cells of a blastocyst (days 5-7) [201].  Embryo prioritization for 
uterine transfer following IVF involves daily morphological screening which is a grading system 
where the rate of cell division is determined to identify embryos that theoretically have the best 
chance for survival and implantation [202].  This system assesses expansion and hatching, as well 
as the cellular density of the trophectoderm and inner cell mass (Figure 10.11) [203].  This can be 
performed by a trained embryologist or through time-lapse technology where cameras within 
the incubator have the ability to record and document growth patterns  [204].  Time-lapse has 
some advantages in that it can continuously monitor the timing of developmental events without 
exposing the embryo to sub-optimal environments [204].  Prior to embryo transfer, the uterine 
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lining is prepared so that it is receptive to implantation.  This occurs either during the luteal phase 
of a natural cycle or after treatment with estrogen and progesterone during a frozen cycle [205].  
Embryo transfer can then occur at any time between the cleavage stage (days 2-4) and the 
blastocyst stage (days 5-6) of development [206].  The number of embryos transferred at one 
time can vary depending on the age of the patient, the quality of the embryos, and previous 
attempts at IVF.  However, the American Society for Reproductive Medicine (ASRM) and the 
Society for Assisted Reproductive Technology (SART) have set guidelines for determining the 
appropriate number of embryos for transfer in an effort to maximize success while reducing the 
number of twin gestations.  These recommendations allow for anywhere between 1-3 embryos 
transferred based on patient prognosis [207]. 
 
Figure 10.11:  Examples of different grades of human blastocysts:  (a) 3AA; (b) 3AB; (c) 3BA; (d) 
4AA; (e) 4AB; (f) 4BA; (g) 4CC; (h) 5AA; (i) 5CA.  Image from Van den Abbeel, 2013. 
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10.7.1. Pre-implantation Genetic Testing  
Evaluation of embryos using morphology alone results in relatively low success rates with only 
about 25% of IVF cycles resulting in a live birth [208].  The use of pre-implantation genetic testing 
has improved these rates, particularly for women over 37 years of age [209].   
Pre-implantation genetic testing is a broad term used to describe the chromosome analysis of 
cells from an oocyte or embryo for the purpose of embryo selection for uterine transfer [210].  
The first successful chromosome screening procedure was performed by Professor Alan 
Handyside in 1990 to identify the Y chromosome in embryos at risk for recessive X chromosome-
linked diseases [211].  Shortly after this, fluorescence in situ hybridization (FISH) was developed 
to detect structural chromosomal aberrations in a handful of specific chromosomes involved in 
common aneuploidies [210].  However, it was later found that these early techniques, only 
looking at specific chromosomes, failed to improve pregnancy rates with IVF [212].  More current 
methodologies include the use of array CGH, quantitative PCR, and next-generation sequencing 
which reliably identify aneuploidy on all 23 chromosome pairs  [213].   
With epigenetic marking of the genome occurring during gametogenesis and embryogenesis, 
genetic imprints are vulnerable.   Despite the fact that there are very few genes known to be 
imprinted, the majority of these play a role in regulating pre- or post-natal growth [214] and there 
are a number of places where ART can disrupt normal epigenetic processes [215].  Since erasure 
and acquisition of imprints in male gametes are completed by the spermatid stage, it is unlikely 
that manipulations with mature sperm during ART have a negative impact on the epigenetics of 
the resulting embryo.  However, immature sperm can be a source of epigenetic instability due to 
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the lack of chromatin condensation in these cells which delay oocyte activation and/or result in 
aneuploidy [216].  Also, sperm collected surgically, rather than through ejaculation, have 
different methylation patterns which increase the risk for imprinting errors [217].  Paternal age 
has also been shown to have an effect on miscarriage and this is thought to be caused by other 
epigenetic alterations  [218]. The female gamete, on the other hand, is much more prone to 
epigenetic changes as a result of ART.  In the United States, the majority of women who seek out 
ART are older (>35) and likely have compromised oocytes as a result of advanced maternal age 
[219].  Hormones used during ART to mature and stimulate oocyte production have the potential 
to impact overall oocyte quality resulting in delays in development, reduced cell numbers and 
chromosomal aneuploidies [220].  Also, environmental impacts of the culture system may cause 
epigenetics changes.  Deficiencies in the temperature, pH, and the culture media itself may 
influence epigenetic programing during this sensitive time.  Finally, cryopreservation of either 
gametes or embryos may disrupt the normal methylation processes resulting in imprinting 
disorders [221].    
Studies in sheep have found an increased incidence in large offspring syndrome following in vitro 
culture of embryos which also displayed abnormal methylation levels [222].  Mouse studies have 
also shown altered methylation and expression of imprinted genes following embryo culture 
[223].  Epigenetic alterations have been observed in oocytes, embryos, placental and fetal tissues 
in these mouse models [224-227].  In fact, recent research has suggested that ART, which 
accounts for 1-3% of annual births in industrialized countries, have led to an increased incidence 
of imprinting disorders associated with aberrant methylation [228].  Multiple retrospective 
studies have found an association with assisted reproductive technologies and Beckwith-
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Wiedemann syndrome [229-231].  However, other studies have found no differences in 
methylation in children conceived from ART compared to natural conceptions [232].  While many 
of the animal studies have raised legitimate concerns, there are distinct differences in the 
imprinting processes between different species, as well as different culture conditions between 
research animals and clinical environments [233].  In addition, most human cohorts have been 
compiled retrospectively, comparing infertile couples who have utilized ART with fertile couples 
who conceived naturally [234].  Fertile couples capable of natural conception do not make ideal 
control groups since infertile couples typically have multiple reasons for their infertility (age, 
chromosome abnormalities, cancer, mitochondrial issues, sperm count/motility, etc.) and may 
therefore be at a higher risk for imprinting disorders compared to healthy individuals [58].  With 
infertility being a risk factor in and of itself, it is likely that more severe cases, requiring ART, are 
at an increased risk for imprinting disorders compared to fertile or even sub-fertile populations 
[235].  The extent of what remains unknown in this area of research exemplifies the importance 
of the oocyte and embryo environment during this developmental landscape. 
10.8. Perspectives 
Creating high quality embryos that have the greatest likelihood for implantation and ultimately 
result in healthy live births is the objective of any IVF lab.  However, the biological mechanisms 
behind the reduced implantation potential observed in embryos from women of advanced age, 
in addition to other infertility diagnoses, is not well understood.  There are gaps in the literature 
involving gene expression during early embryo development.  Little is known in the human 
regarding how an embryo implants into the uterus, especially the mechanisms behind what 
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distinguishes the implantation potential of seemingly good-quality embryos.  While morphology 
can assess what appears to be a good quality embryo and PGT-A has allowed the ability to choose 
embryos that are chromosomally normal, neither method can fully predict the likelihood of 
successful embryo implantation.  Identifying the biological factors responsible for reduced 
implantation potential may aid in the improvement of IVF procedures. 
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11.0 Aims of This Thesis 
The overall objective of this thesis was to investigate transcriptomic and genetic modifications 
during pre-implantation embryonic development.  The impacts of advanced maternal age, 
implantation failure, chromosome constitution, and infertility diagnosis were a particular 
focus.  The overall purpose was to better understand the ways in which these factors affect not 
only normal embryo development, but also overall reproductive success.  With this in mind, the 
specific aims were as follows: 
1. To test the hypothesis that embryonic miRNAs are impacted by advanced maternal age 
and/or chromosome constitution. 
2. To test the hypothesis that the embryonic transcriptome is impacted by advanced 
maternal age. 
3. To test the hypothesis that methylation alterations explain differing implantation 
potential among aneuploid blastocysts in correlation with chromosome constitution. 
4. To establish whether underlying infertility diagnoses (polycystic ovaries, male factor, and 
unexplained) have an impact on the transcriptome of developing blastocysts. 
5. To explore the presence of pathogenic variants in patients with premature diminished 
ovarian reserve and any downstream molecular impact on the developing embryo. 
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11.1. Specific Aim 1 
To test the hypothesis that embryonic miRNAs are impacted by advanced maternal age and/or 
chromosome constitution. 
The following published work is presented for this specific aim: 
BR McCallie, JC Parks, Strieby AL, WB Schoolcraft, MG Katz-Jaffe.  Human Blastocysts Exhibit 
Unique MicroRNA Profiles in Relation to Maternal Age and Chromosome Constitution.  J Assist 
Reprod Genet. 2014 Jul;31(7):913-9. 
11.1.1. My Personal Contribution to the Work 
For this study I performed all of the RNA lysis, reverse transcription, pre-amplification, 
quantitative real-time PCR and corresponding analyses.  I also wrote and edited the manuscript. 
11.1.2. Chapter Summary 
The purpose of this study was to determine miRNA expression in human blastocysts relative to 
both advanced maternal age and chromosome constitution to better understand the effects on 
pre-implantation embryonic development.  Three distinct groups of vitrified day 5 blastocysts 
were analyzed:  euploid blastocysts from young oocyte donors, euploid blastocysts from women 
in their forties, and aneuploid blastocysts from women in their forties.  Blastocysts were warmed 
and then lysed prior to performing reverse transcription and pre-amplification.  Taqman® array 
cards were utilized for quantitative real-time PCR to obtain a list of differentially expressed 
miRNAs and pathway analysis was performed to determine significant biological processes and 
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pathways.  Immunofluorescence staining was performed on additional blastocysts to determine 
if altered miRNA expression was having an effect on downstream target gene expression.   
A unique miRNA expression signature was found relative to age but independent of ploidy status.  
In total, 42 miRNAs were differentially expressed in the blastocysts from older women, the vast 
majority having increased expression.  Additionally, 11 miRNAs were exclusively expressed in 
blastocysts from this older cohort.  Analysis of expression profiles between euploid and aneuploid 
blastocysts revealed 38 differentially expressed miRNAs with 3 being exclusively expressed in 
aneuploid blastocysts.  Pathway analysis of these exclusively expressed miRNAs revealed 
biological processes related to apoptosis, and cell proliferation and differentiation.  MiR-93 was 
exclusively expressed in blastocysts from women in their forties and further increased in 
expression in aneuploid blastocysts.  Immunofluorescence staining was performed on SIRT1, a 
target gene of MiR-93 which is involved in aging and oxidative stress defense.  Decreased 
expression of the SIRT1 protein was observed in the aged blastocysts compared to young donor 
oocytes. 
11.1.3. Introduction 
MicroRNAs are endogenous, small (21–22 nucleotides), noncoding RNA molecules that post-
transcriptionally regulate the expression of mRNA targets in a sequence specific manner[236].  
To date, more than 1,500 human miRNAs have been identified and catalogued 
(http://mirbase.org/). Studies have shown that a significant proportion of miRNAs are conserved 
across vertebrates with many miRNAs predicted to regulate the expression of hundreds of 
different genes [237]. MicroRNAs have also been associated with a variety of biological functions 
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including cell proliferation, apoptosis, metabolism, aging, and development [238, 239].  In the 
complex world of aging, environmental stimuli and genetic factors play important contributory 
roles. A number of aging associated pathways have been characterized including the 
insulin/insulin-like growth factor signaling pathway, which was identified through loss of function 
alleles of the genes age-1 and daf-2 to extend longevity in C. elegans [240].  MicroRNAs have also 
been shown to play a role in regulating gene and protein signatures which affect the aging 
process at both the tissue and organism level, and can act in both pro and anti-longevity 
regulatory pathways [241]. In an aging human population, nine miRNAs displayed decreased 
expression when compared to young individuals, with five of these decreased miRNAs 
characterized in cancer pathogenesis [239].  Decreased miRNA expression is also common during 
cellular senescence and an increasing number of senescent cells are accumulated with the aging 
process [242].  Women in the developed world are increasingly postponing childbearing until well 
into their fourth and fifth decades.  This trend is leading to an aging reproductive society and the 
fertility complications that are well documented with advanced maternal age defined as >35 
years (ACOG Committee Opinion 2010; www.acog.org). One of the main contributors to maternal 
age-related infertility is the declining number of oocytes as a woman approaches menopause, in 
addition to the compromised quality of these remaining oocytes [243]. Oocytes from women 
with advanced maternal age have been shown to have increased mitochondria number and size 
which could be contributing to a decline in developmental potential [244].  Chromosome 
abnormalities are also more prevalent in the aged oocyte, resulting in compromised oocyte 
quality and clinical pregnancies that contribute to >70 % of spontaneous miscarriages [243, 245]. 
Chromosome abnormalities have similarly been identified in malignant cells from numerous 
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cancer types which, along with other genetic alterations, including distorted miRNA expression, 
are associated with disease prognosis and cancer progression [246].  Given that maternal aging 
is the most significant risk factor associated with human infertility, the aim of this study was to 
investigate the association between advanced maternal age, embryo chromosome constitution 
and miRNA expression. In the present study, we evaluate whether advanced maternal age and 
embryo chromosome constitution impact miRNA function and contribute to the decline of 
oxidative defense mechanisms in aged and aneuploid blastocysts. 
11.1.4. Methods and Materials 
Surplus, cryopreserved, in vitro produced, day 5 blastocysts (n=75) from the Colorado Center for 
Reproductive Medicine were donated to research with patient consent and Institutional Review 
Board approval.  All blastocysts analyzed were of equivalent morphology and graded as expanded 
blastocysts on day 5 of development: 
A) Chromosomally normal blastocysts from young, oocyte donors (mean 26.4 years),         B) 
Chromosomally normal blastocysts from women in their forties (range 40–44 years), and C) 
Chromosomally aneuploid blastocysts, all of which were incompatible with life, from women in 
their forties (range 40–44 years).  The infertile female patients presented for infertility treatment 
with normal ovarian reserve for their respective maternal age, and had an expected ovarian 
response to stimulation.  Their indication for IVF was only advanced maternal age with no other 
infertility diagnosis including no male factor. 
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11.1.4.1. Blastocyst Culture 
All gamete and embryo manipulations were performed in a pediatric isolette to control for 
humidity, temperature, and pH fluctuations.  Semen preparation was performed using a 50-70-
95 discontinuous gradient of Pure Sperm (Nidacon, Gothenburg, Sweden) and the resulting pellet 
was washed in fertilization medium.  ICSI was performed on mature oocytes that had been 
denuded in hyaluronidase using a Nikon inverted microscope (Nikon Instruments, Melville, NY) 
with Narashige micromanipulators (Narashige International, East Meadow, NY).  Assessment of 
fertilization took place 15–18 h after insemination.  Embryos with two pronuclei were group 
cultured for 96 h in microdrops of sequential media (Cooper Surgical, Trumbull, CT) at 5% O2, 6% 
CO2 at 37 °C. On the morning of day 5, blastocyst grading was performed using the Gardner and 
Schoolcraft system [247]. 
11.1.4.2. Blastocyst Biopsy of Trophectoderm Cells for Comprehensive Chromosome 
Screening 
Expanded blastocysts underwent biopsy of 3–5 trophectoderm cells to determine chromosome 
constitution using previously published standard laboratory techniques [248].  Briefly, under an 
inverted Nikon microscope (Nikon) with Narishige manipulators and injectors (Narishige), 
trophectoderm cells were aspirated into a biopsy pipette and detached from the blastocyst by 
firing several pulses of a laser (Hamilton-Thorne Research, Beverly MA) at the area of constriction 
to separate them from the rest of the blastocyst.  The aggregate of TE cells was placed intact into 
a PCR tube after several washes through hypotonic solution. 
Comprehensive chromosome screening for all 23 pairs of human chromosomes was performed 
using a quantitative real-time PCR based method developed by Reproductive Medicine 
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Associates of New Jersey [249].  Briefly, trophectoderm cells were lysed in KOH and incubated at 
65 °C for 10 min.  The lysed DNA was then used as a template for multiplex pre-amplification of 
96 loci with the use of TaqMan CopyNumber Assays and TaqMan Pre-amplification Master Mix 
as recommended by the supplier (Life Technologies, Carlsbad CA) in a 50μl reaction for 18 cycles.  
Real-time PCR was then performed in quadruplicate for each individual 96 loci on a 384-well plate 
using TaqMan Gene Expression Master Mix as recommended by the supplier (Life Technologies) 
in a 5ul reaction.  A novel method of the standard delta-delta threshold cycle method of relative 
quantitation was applied [249]. 
11.1.4.3. Blastocyst Vitrification and Warming 
Following TE biopsy, blastocysts were vitrified using the Cryotop with a DMSO/ethylene glycol 
protocol developed by Kuwayama et al. [250] and used routinely in the IVF laboratory.  
Blastocysts were then stored in liquid nitrogen.  Upon study recruitment blastocysts were 
warmed in a thawing solution of 1 mol/L sucrose for 45–60 s at 37°C. Warmed embryos were 
then transferred to a dilution solution of 0.5 M sucrose for 3 min, followed by washing with 
medium containing no sucrose for 5 min before placing in embryo culture media (Vitrolife, 
Englewood, CO) for re-expansion.   
11.1.4.4. Reverse Transcription, Pre-Amplification, and Quantitative Real-Time PCR 
After warming, blastocysts were lysed using a previously validated protocol from the TaqMan® 
MicroRNA Cells-to- Ct™ Kit (Life Technologies) with minor modifications.  Briefly, blastocysts were 
washed through phosphate-buffered saline (PBS) before being transferred into 10ul of a 
lysis/DNase solution and incubated at room temperature for 8 min.  1ul of Stop Solution was then 
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added and incubated for an additional 2 min at room temperature.  The lysed blastocyst was 
snap-frozen in liquid nitrogen and stored at −80°C.  A negative control was also utilized 
throughout the procedure to ensure the absence of false amplification.  Samples were reverse 
transcribed using the Megaplex™ RT Primers Human Primer Pool A and the TaqMan® MicroRNA 
Reverse Transcription Kit (Life Technologies).  4.3ul of a master mix containing 20 mM dNTPs, 
75U reverse transcriptase, 2U ribonuclease inhibitor, 22.5mM MgCl2, and 1× RT Primers was 
combined with 3.2ul of each sample and incubated for 40 cycles at 16 °C for 2 min, 42 °C for 1 
min, and 50 °C for 1 s, followed by a 5 min hold at 85 °C.  The entire volume of cDNA was then 
pre-amplified by combining it with 17.5ul of Megaplex™ PreAmp Primers Human Pool A and 
TaqMan® Pre-Amp Master Mix and incubated using the following thermal cycling profile: 95 °C 
for 10 min, 55 °C for 2 min, 72 °C for 2 min, 14 cycles at 95 °C for 15 s and 60 °C for 4 min, with a 
final hold at 99.9 °C for 10 min.  The pre-amplified product was then diluted by adding 75ul of 
0.1× TE for a final volume of 100ul and stored at −20 °C until real-time PCR was performed. 
Quantitative real-time PCR was performed by combining 9ul of the diluted pre-amplified product 
to 450ul of TaqMan® Universal PCR Master Mix, No AmpErase® UNG and 441ul of nuclease-free 
water.  100ul of this mixture was added to each of the 8 ports on the TaqMan® Array Human 
MicroRNA A Card, which was then centrifuged, sealed, and run on the ABI7900HT Fast Real-Time 
PCR System at 50 °C for 2 min, 94.5 °C for 10 min, and 40 cycles at 97 °C for 30 s and 59.7 °C for 
1 min.  Cycle thresholds were analyzed using RQ Manager 1.2.1 (Life Technologies) and statistical 
analysis for PCR was performed using the internal constant house-keeping miRNA, MammU6, 
and REST 2009 software (Qiagen, Valencia, CA).  REST software uses randomization and 
bootstrapping techniques to determine statistical significance.  The mathematical model uses the 
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correction for exact PCR efficiencies and the mean crossing point deviation between sample and 
control groups.  The resulting expression ratio is tested for significance by a Pair Wise Fixed 
Reallocation Randomization Test.  Significance was defined at P<0.05.  A list of exclusively 
expressed miRNAs was uploaded into Pathway Studio (Elsevier, Waltham MA) to identify 
relationships between these miRNAs, their predicted target genes, and biological processes and 
pathways. 
11.1.4.5.  Immunofluorescence 
Cryopreserved blastocysts were warmed and transferred into a dish containing 400ul 2% 
formaldehyde microtubule stabilization buffer (MTSB-XF) [23] and then incubated at 37°C for 30 
min. Blastocysts were then washed in 3-(N-morpholino)propanesulfonic acid (MOPS) containing 
no protein, transferred into a dish containing the primary antibody, SIRT1 (Abcam, Cambridge 
MA) (1:100 dilution), and incubated at 4 °C overnight in a humidity chamber.  The next morning, 
blastocysts were put through a series of three washes consisting of PBS supplemented with 1 % 
BSA, 0.2 % powdered milk, 2 % normal goat serum, 0.1 M glycine, 0.1 % Triton-X, and 2 % sodium 
azide before an overnight incubation at 4 °C with the secondary antibody, polyclonal goat anti-
rabbit IgG conjugated to DyLight® 488 (Abcam) (1:500 dilution).  Following this final incubation, 
blastocysts were washed another three times before mounting onto glass slides using 
VECTASHIELD® Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA) to visualize 
nuclei.  Slides were viewed under an Olympus BX52 florescent microscope at 40× using the DAPI 
and FITC filters and then photographed.  All analysis was performed blinded using Metamorph 
Image Analysis Software and average FITC intensities were recorded (Molecular Devices, 
Sunnyvale, CA).  Images were standardized for exposure time and image scaling.  The SIRT1 
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antibody was tested for specificity and a negative control was performed by staining with only 
the secondary antibody, which resulted in no fluorescence. 
11.1.5. Results 
In total, 60 out of 377 miRNAs (16 %) were expressed across morphologically equivalent human 
blastocysts, with a unique microRNA expression signature being observed relative to maternal 
age and independent of blastocyst chromosome constitution.  Positive expression was defined 
as a Ct value ≤36 in at least 5 out of 6 samples in each group; negative expression was defined as 
a Ct value ≥37 in at least 5 out of 6 samples in each group.  Statistical analysis comparing miRNA 
expression profiles between young oocyte donor derived blastocysts (n=5) and blastocysts 
produced from women in their forties (n=5) revealed 42 differentially expressed miRNAs (P<0.05; 
Table 11.1).  The vast majority of these 42 miRNAs displayed increased expression in the 
blastocysts derived from older women, with only 2 miRNAs showing decreased expression (miR-
186 and miR-628-5p; P<0.05).  In addition, 11 miRNAs were exclusively expressed in blastocysts 
from women in their forties (miR-15b, miR-18a, miR-184, miR-195, miR-20b, miR-212, miR-222, 
miR-367, miR-515-5p, and miR-518a-3p, miR-93; P<0.05) (Table 11.1). 
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Table 11.1: Analysis of miRNA expression in euploid blastocysts derived from young oocyte 
donors in comparison to euploid blastocysts from women in their forties. In total, 60 miRNAs 
were expressed with 42 showing differential expression (P<0.05).  Fold changes with an * were 
statistically significant (P<0.05).  miRNAs with Ct values = 40 were considered not present. 






hsa-miR-106a-4395280 28.9 27.32 3.7* 
hsa-miR-106b-4373155 31.48 30.84 1.9 
hsa-miR-125a-5p-4395309 32.75 31.95 2.2 
hsa-miR-146b-5p-4373178 32.88 29.45 >10* 
hsa-miR-15b-4373122 40 32.07 >10* 
hsa-miR-17-4395419 27.94 24.46 >10* 
hsa-miR-184-4373113 40 32.32 >10* 
hsa-miR-186-4395396 31.08 32.1 0.6* 
hsa-miR-18a-4395533 40 31.94 >10* 
hsa-miR-191-4395410 25.5 25.67 1.1 
hsa-miR-192-4373108 31.48 28.27 >10* 
hsa-miR-193b-4395478 31.27 29.01 5.9* 
hsa-miR-195-4373105 40 33.6 >10* 
hsa-miR-197-4373102 31.87 29.63 5.9* 
hsa-miR-19b-4373098 29.05 25.43 >10* 
hsa-miR-200c-4395411 30.24 27.48 8.4* 
hsa-miR-203-4373095 30.91 29.93 2.4* 
hsa-miR-20b-4373263 40 33.43 >10* 
hsa-miR-212-4373087 40 30.26 >10* 
hsa-miR-218-4373081 40 40 N/A 
hsa-miR-222-4395387 40 29.79 >10* 
hsa-miR-24-4373072 28.05 27.18 2.3* 
hsa-miR-28-3p-4395557 32 29.67 6.2* 
hsa-miR-302a-4378070 31.18 28.91 6.0* 
hsa-miR-302b-4378071 29.22 27.64 3.7* 
hsa-miR-302c-4378072 29.82 29.38 1.7 
hsa-miR-30c-4373060 32.07 29.14 9.4* 
hsa-miR-31-4395390 31.62 29.32 6.1* 
hsa-miR-320-4395388 28.89 28.22 2.0* 
hsa-miR-323-3p-4395338 30.62 29.63 2.5* 
hsa-miR-342-3p-4395371 31.19 30.04 2.8 
hsa-miR-345-4395297 31.35 29.27 5.2* 
hsa-miR-367-4373034 40 29.66 >10* 
hsa-miR-371-3p-4395235 28.13 26.83 3.1* 
hsa-miR-372-4373029 21.65 20.59 2.6* 
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hsa-miR-373-4378073 30.19 29.26 2.4 
hsa-miR-374a-4373028 32.45 30.94 3.5* 
hsa-miR-374b-4381045 32.29 29.53 8.4* 
hsa-miR-381-4373020 40 40 N/A 
hsa-miR-454-4395434 32.94 31.3 3.9* 
hsa-miR-484-4381032 28.16 27.26 2.3* 
hsa-miR-508-3p-4373233 40 40 N/A 
hsa-miR-512-3p-4381034 22.95 22.78 1.4 
hsa-miR-515-3p-4395480 30.6 31.9 0.5 
hsa-miR-515-5p-4373242 40 32.99 >10* 
hsa-miR-517a-4395513 28.48 26.55 4.7* 
hsa-miR-517c-4373264 29.06 26.89 5.6* 
hsa-miR-518a-3p-4395508 40 32.35 >10* 
hsa-miR-518b-4373246 30.13 29.68 1.7 
hsa-miR-518e-4395506 29.36 29.02 1.6 
hsa-miR-518f-4395499 32.2 30.84 3.2* 
hsa-miR-519a-4395526 30.38 28.74 3.9* 
hsa-miR-519d-4395514 31.12 28.61 7.1* 
hsa-miR-520b-4373252 32.88 31.63 2.9 
hsa-miR-520g-4373257 29.87 29.58 1.5 
hsa-miR-521-4373259 34.09 33.97 1.3 
hsa-miR-522-4395524 31.89 31.47 1.7 
hsa-miR-525-3p-4395496 30.39 29.15 2.9 
hsa-miR-548a-3p-4380948 33.02 32.23 2.1 
hsa-miR-628-5p-4395544 32.5 33.39 0.7* 
hsa-miR-886-5p-4395304 29.97 29.24 2.1 
hsa-miR-93-4373302 40 31.73 >10* 
MammU6-4395470 22.2 22.51 1.0 
Negative expression was only observed for these 11 miRNAs in young oocyte donor derived 
blastocysts.  Statistical analysis comparing miRNA expression profiles between chromosomally 
normal (n=5) and abnormal blastocysts (n=5) revealed a panel of 38 differentially expressed 
miRNAs (P<0.05), with 29 (74 %) showing increased expression in chromosomally abnormal 
blastocysts (Table 11.2).  Three of these miRNAs were exclusively expressed in chromosomally 
abnormal blastocysts including; miR-218, miR-381 and miR-508-3p (P<0.05) (Table 11.2).   
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Table 11.2: Analysis of miRNA expression comparing euploid blastocysts to aneuploid blastocysts 
from women in their forties revealed 38 differentially expressed miRNAs (P<0.05).  Fold changes 
with an * were statistically significant (P<0.05).  miRNAs with Ct values = 40 were considered no 
present. 






hsa-miR-106a-4395280 27.32 27.64 0.8 
hsa-miR-106b-4373155 30.84 29.78 2.1* 
hsa-miR-125a-5p-4395309 31.95 33.46 <0.5* 
hsa-miR-146b-5p-4373178 29.45 28.08 2.6* 
hsa-miR-15b-4373122 32.07 31.32 1.7 
hsa-miR-17-4395419 24.46 25.38 0.5 
hsa-miR-184-4373113 32.32 31.2 2.2 
hsa-miR-186-4395396 32.1 32.04 1.0 
hsa-miR-18a-4395533 31.94 31.29 1.6 
hsa-miR-191-4395410 25.67 25.96 0.8 
hsa-miR-192-4373108 28.27 28.22 1.0 
hsa-miR-193b-4395478 29.01 28.12 1.9* 
hsa-miR-195-4373105 33.6 31.92 3.2* 
hsa-miR-197-4373102 29.63 29.77 0.9 
hsa-miR-19b-4373098 25.43 26.5 0.5* 
hsa-miR-200c-4395411 27.48 26.75 1.7* 
hsa-miR-203-4373095 29.93 30.28 0.8 
hsa-miR-20b-4373263 33.43 32.31 2.2* 
hsa-miR-212-4373087 30.26 31.01 0.6 
hsa-miR-218-4373081 40 16.21 >10* 
hsa-miR-222-4395387 29.79 30.8 0.5 
hsa-miR-24-4373072 27.18 27.04 1.1 
hsa-miR-28-3p-4395557 29.67 29.1 1.5* 
hsa-miR-302a-4378070 28.91 26.99 3.8* 
hsa-miR-302b-4378071 27.64 26.2 2.7* 
hsa-miR-302c-4378072 29.38 30.42 0.5* 
hsa-miR-30c-4373060 29.14 27.88 2.4* 
hsa-miR-31-4395390 29.32 29.55 0.9 
hsa-miR-320-4395388 28.22 27.78 1.4* 
hsa-miR-323-3p-4395338 29.63 29.61 1.0 
hsa-miR-342-3p-4395371 30.04 29.44 1.5* 
hsa-miR-345-4395297 29.27 29.85 0.7 
hsa-miR-367-4373034 29.66 28.96 1.6* 
hsa-miR-371-3p-4395235 26.83 26.29 1.5* 
hsa-miR-372-4373029 20.59 20.23 1.3* 
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hsa-miR-373-4378073 29.26 28.08 2.3* 
hsa-miR-374a-4373028 30.94 30.44 1.4* 
hsa-miR-374b-4381045 29.53 28.57 1.9* 
hsa-miR-381-4373020 40 27.91 >10* 
hsa-miR-454-4395434 31.3 29.92 2.6* 
hsa-miR-484-4381032 27.26 26.69 1.5* 
hsa-miR-508-3p-4373233 40 32.71 >10* 
hsa-miR-512-3p-4381034 22.78 23.01 0.9 
hsa-miR-515-3p-4395480 31.9 30.88 2.0* 
hsa-miR-515-5p-4373242 32.99 32.13 1.8 
hsa-miR-517a-4395513 26.55 27.16 0.7 
hsa-miR-517c-4373264 26.89 27.8 0.5* 
hsa-miR-518a-3p-4395508 32.35 32.35 1.0 
hsa-miR-518b-4373246 29.68 31.01 <0.5* 
hsa-miR-518e-4395506 29.02 30.07 0.5* 
hsa-miR-518f-4395499 30.84 19.66 >10* 
hsa-miR-519a-4395526 28.74 28.63 1.1 
hsa-miR-519d-4395514 28.61 29.75 0.5 
hsa-miR-520b-4373252 31.63 30.51 2.2* 
hsa-miR-520g-4373257 29.58 30.93 0.4* 
hsa-miR-521-4373259 33.97 32.22 3.4* 
hsa-miR-522-4395524 31.47 31.97 0.7* 
hsa-miR-525-3p-4395496 29.15 29.2 1.0 
hsa-miR-548a-3p-4380948 32.23 32.28 1.0 
hsa-miR-628-5p-4395544 33.39 15.1 >10* 
hsa-miR-886-5p-4395304 29.24 31.66 0.2* 
hsa-miR-93-4373302 31.73 31.29 1.4* 
MammU6-4395470 22.51 22.51 1.0 
Pathway analysis using Pathway Studio software generated several pathways and biological 
processes for the exclusively expressed miRNAs including apoptosis, cell proliferation, and cell 
differentiation. 
MiR-93 was exclusively expressed in blastocysts from women in their forties and further 
increased in expression with an abnormal chromosome constitution (P<0.05).  In a recent study, 
increased expression of miR-93 was shown to have been associated with aging in rat liver [251].  
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Further investigation suggested SIRT1, an oxidative stress defense protein, as a target gene of 
miR-93, and studies using Western blotting validated the repression of SIRT1 with the increased 
expression of miR-93 [251].  We performed immunofluorescence staining for the SIRT1 protein 
in human blastocysts from women in their forties (n=29) and blastocysts from young, donor 
oocytes (n=31).  SIRT1 was observed in the nucleus of all blastocyst cells and this was confirmed 
by overlay with a nuclear DAPI stain. Nuclear localization of SIRT1 has been previously reported 
[13].  A significant decrease in expression of the SIRT1 protein was found in the aged blastocysts 
compared to blastocysts from young oocyte donors (Figure 11.1).  Therefore, increased 
expression of miR-93 reflects a repression of its target gene, SIRT1, a vital oxidative defense gene, 
in human blastocysts from women of advanced maternal age. 
 
Figure 11.1: Immunofluorescence staining for the SIRT1 protein in human blastocysts from 
women in their forties (n=29) and blastocysts from young, donor oocytes (n=31) to investigate 
this known miR-93 target gene.  Immunofluorescence staining revealed a significant decrease in 
expression of SIRT1 protein (FITC, green) in the blastocysts from women of advanced maternal 
age.  DAPI (blue) was used as a counter stain for the nucleus. 
50 μm 50 μm 50 μm 50 μm 
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11.1.6. Discussion  
It is well documented that maternal aging is the most significant risk factor associated with 
human infertility, and that embryo chromosome constitution is associated with the decline in 
reproductive potential as women enter their forties.  The aim of this study was to investigate an 
association between advanced maternal age, embryo chromosome constitution and miRNA 
expression.  These results indicate that advanced maternal age and embryo chromosome 
constitution impact miRNA expression and target gene function, and may specifically contribute 
to the decline of oxidative defense mechanisms in aged blastocysts.  MicroRNA profiling of 
blastocysts from women in their forties compared to blastocysts from young fertile donor 
oocytes revealed 42 differentially expressed miRNAs including 11 miRNAs that were exclusively 
expressed in blastocysts from women of advanced maternal age. One of these exclusively 
expressed microRNAs was miR-15b.  This microRNA has been shown to be involved in the cell 
cycle and its over-expression results in cell cycle arrest [252].  Another exclusively expressed 
miRNA in our study was miR-93 which is associated with oxidative stress and was also identified 
to be further up-regulated with an abnormal chromosome constitution of an aged blastocyst.  
Oxidative stress negatively alters cell-signaling communication required for normal cell growth 
and proliferation. Oxidative stress is considered one of the causes of normal aging [253] and may 
contribute to several disease states affecting female reproduction, including poor oocyte quality 
[254].  SIRT1, a NAD-dependent histone deacetylase, has been identified in anti-oxidative stress 
regulation during aging, possibly by depleting ROS to maintain cell survival [255].  MiR-93 has 
been shown to target oxidative stress defense proteins, including SIRT1 [256].  During the aging 
process, miR-93 potentially reduces the production of SIRT1 proteins and their transcription 
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factors, which would result in the loss of oxidative defense [251].  Immunofluorescence staining 
for the SIRT1 protein in blastocysts from women in their forties, compared to blastocysts from 
young fertile donor oocytes, showed decreased expression of SIRT1 in aged blastocysts.  
Therefore, it appears that there is an association between the increased expression of miR-93 in 
aged blastocysts that could reflect a repression and down-regulation of its target gene, SIRT1.  In 
summary, this novel study showed that human blastocysts exhibit unique miRNA expression 
profiles in relation to maternal age and chromosome constitution.  A set of 11 miRNAs exclusively 
characterized blastocysts from women in their forties and a unique panel of 38 miRNAs were 
differentially expressed in relation to blastocyst chromosome constitution.  MiR-93 was 
exclusively expressed in blastocysts from women in their forties and further up-regulated with 
an abnormal chromosome complement.  Up-regulated miR-93 appears to be associated with an 
inverse down-regulation of targets like SIRT1, resulting in reduced oxidative defense.  Further 
investigations of these miRNAs will reveal critical roles in gene modulation that could reflect 
compromised embryonic development. 
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11.2. Specific Aim 2 
To test the hypothesis that the embryonic transcriptome is impacted by advanced maternal 
age. 
The following published work is presented for this specific aim: 
BR McCallie, JC Parks, GD Trahan, KL Jones, BD Coate, DK Griffin, WB Schoolcraft, MG Katz-Jaffe.  
Compromised Global Embryonic Transcriptome Associated with Advanced Maternal Age.  J Assist 
Reprod Genet.  2019 May;36(5):915-924. 
11.2.1. My Personal Contribution to the Work 
For this study, I designed the primers and performed all of the RNA isolation, reverse 
transcription, quantitative real-time PCR for validation, and corresponding analyses.  I also wrote 
and edited the manuscript. 
11.2.2. Chapter Summary 
The objective of this study was to investigate the underlying molecular networks of blastocysts 
from women of advanced maternal age to better understand the effects of oocyte aging on 
embryo competence and implantation potential.  Cryopreserved, transferrable quality, human 
blastocysts were donated to research with Institutional Review Board (IRB) consent: young, 
fertile, oocyte donor (DC; < 30 years old), and advanced maternal age (AMA; ≥ 42 years old).  RNA 
was isolated from blastocysts prior to library preparation and RNA sequencing.  Derived 
sequences were processed and analyzed followed by pathway analysis and qPCR for validation.  
RNA sequencing revealed 2,688 significant differentially expressed genes between DON and AMA 
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blastocysts.  2,551 (95%) of these genes were decreased and 137 (5%) genes displayed increased 
transcription in the blastocysts from older women, representing an overall global decrease of 
gene expression with maternal aging.  Pathway analysis revealed three distinct, interrelated, 
molecular signaling networks known to be critical for embryo and fetal development:  CREBBP, 
ESR1 and SP1.  41 genes regulated by the CREBBP network were found to be significantly 
decreased in AMA blastocysts, in addition to 62 genes regulated by ESR1 and 56 genes regulated 
by SP1.  Validation of genes within these networks (ALK, CCND3, EPSTI1, GNAS, LTBP3, MAPK8IP1, 
NDRG1, SREBF1, TLE2, TNFRSF10A, and TSPAN9) confirmed the global decreased transcription in 
AMA blastocysts compared to DC.   
11.2.3. Introduction 
The effects of female aging on fertility are well described and impact, among others, ovarian 
reserve, oocyte quality and pregnancy complications [257].  Chromosome aneuploidy is a 
significant contributor to infertility, with maternal age being the greatest risk factor [258].  
Meiotic events occurring during oogenesis, particularly the prolonged arrest in dictyate, increase 
the susceptibility of chromosome segregation errors and this is observed in the oocytes from 
older women [157].   The association between increasing maternal age and the frequency of 
chromosome aneuploidy in human conception, including Down syndrome, has been extensively 
documented [259].    This leads to an increased risk of spontaneous abortion as women age, with 
more than half of all pregnancies resulting in a fetal loss by the time a woman reaches 42 years 
of age [260].  In fact, 75% of spontaneous miscarriages in women 35 years and older are the 
direct result of chromosome anomalies, compared to 50% in mothers younger than 35 years of 
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age [261].  Infertile women of advanced maternal age can utilize assisted reproductive 
technologies and pre-implantation genetic testing for aneuploidy to selectively transfer euploid 
embryos with successful clinical outcomes.  Nevertheless, these women do see a decrease in live 
birth rates compared to their younger counterparts, indicating a reduced implantation potential 
independent of chromosome constitution.   
Oogenesis is a process that involves a complex series of nuclear and cytoplasmic events that 
prepare the oocyte for fertilization and initiate pre-implantation embryo development until the 
activation of the embryonic genome [262, 263].  The quality of the oocyte will determine an 
embryo’s developmental potential and an aged oocyte can have dysfunctions in the cellular 
organelles including, among others, the endoplasmic reticulum and mitochondria which play a 
role in Ca2+ storage and absorption, culminating in apoptosis [264-266].  This storage and 
redistribution of calcium by the endoplasmic reticulum is responsible for cell activation during 
fertilization and can affect embryo development and implantation [267].  Mitochondria are 
essential for oocyte maturation, fertilization, and development since they act as the major source 
of ATP during pre-implantation embryonic development [268].  Damage to mitochondria can also 
cause increased production of reactive oxygen species (ROS), via oxidative phosphorylation 
during ATP production, and accumulate over time to expose the aged oocyte to oxidative stress 
[269].  Taken together, this can promote the aging process by negatively influencing cell signaling 
pathways that are involved in proliferation, differentiation, and apoptosis which then result in 
DNA damage or developmental arrest [270, 271]. 
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Aging can also impact epigenetic factors, specifically histone modifications, which are essential 
for oocyte development.  [272].  There are several forms of modifications at the histone amino 
termini including methylation, acetylation, phosphorylation and ubiquitination, all of which play 
important roles in cell cycle progression, DNA replication and repair, and transcriptional activity 
[273-275].  Histone acetylation in particular is critical for these cellular functions, as well as 
regulating chromosome segregation and various chromatin-based processes [276].  In 
mammalian oocytes, histones are deacetylated by histone deacetylase (HDAC) genes during 
meiosis and inhibitions to HDAC activity have been reported to induce aneuploidy and early 
embryonic death in mice [276, 277]. 
There is currently limited knowledge of how advanced maternal aging impacts the 
developmental competence of an embryo on a molecular level.  More recently, a study looked 
at the effects of parental age on downstream gene expression in human blastocysts and found 
that maternal age had a significant impact on changes in the blastocyst transcriptome with more 
than 800 genes having reduced expression as maternal age increased (ranging from 31 to 41 
years of age) [278].  Among these down-regulated genes, several were considered to be 
important for meiotic chromosomal segregation, cell cycle control, and embryo growth and 
implantation.   
The aim of this study was to elucidate the cellular transcriptome of human blastocysts from 
women of considerable advanced maternal age (≥42 years), to further the understanding of 
oocyte aging and its impact on embryonic competence and reproductive success.  This knowledge 
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will provide a valuable molecular explanation, independent of chromosome constitution, for the 
lower success rates observed in this patient population. 
11.2.4. Methods and Materials 
11.2.4.1. Human Blastocysts 
Surplus, cryopreserved, transferrable quality (grade ≥ 3BB) human blastocysts were fertilized 
using intracytoplasmic sperm injection and sequentially cultured under low oxygen conditions 
prior to being donated to research with Institutional Review Board approval and patient consent: 
young, oocyte donor control with no male factor infertility (DC < 30 years; n=12 from 6 different 
patients), and advanced maternal age with no male factor or other significant female factor 
infertility (AMA ≥ 42 years old; n=12 from 12 different patients).  Blastocysts were identified by 
PGT-A to be void of autosomal chromosomal aneuploidies and were warmed following previously 
published vitrification protocols [250].  All fathers were ≤ 48 years of age and therefore not 
considered to be advanced paternal age. 
11.2.4.2. RNA Isolation 
RNA was isolated from individual blastocysts using the PicoPure™ RNA Isolation Kit (Applied 
Biosystems, Foster City CA) with minor modifications to the manufacturer’s protocol.  Briefly, 
blastocysts were lysed at 42°C for 30 minutes in 10ul of Extraction Buffer.  One volume of 70% 
EtOH was mixed with each sample prior to loading onto a pre-conditioned purification column.  
Each sample was on-column deoxyribonuclease treated at room temperature for 15 minutes 
(Qiagen, Germantown MD).  After several washes, RNA was eluted in 20ul of Elution Buffer.   
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11.2.4.3. RNA Sequencing and Bioinformatic Analysis 
The entirety of the purified RNA from each blastocyst (n=12, six from each group) was utilized to 
prepare sequencing libraries using the SMARTer® Ultra® Low Kit (Clontech Laboratories, Fremont 
CA) following manufacturer’s instructions and then sequenced on the HiSEQ 4000 (Illumina, San 
Diego CA) as single pass 50bp reads.  Derived sequences were processed by performing quality 
checks and normalization on each read and then mapping them to the human genome (build 
GRCh38) using Trimmomatic v0.36 [279], GMAP-GSNAP v2014-12-17 [280], SAMtools v1.5 [281], 
and Cufflinks v2.2.1 [282].  Transcripts with no reads across all samples, as well as transcripts in 
the bottom quintile based on mean expression across all samples, were excluded from analysis.  
A log transformation was performed prior to statistical analysis which included a two-sample, 
two-sided, independent Student’s t-test (significance at Q<0.05).  The false discovery rate was 
then adjusted using the Benjamini-Hochberg procedure and the expression log ratio was used for 
each differentially expressed transcript.  Pathway analysis was performed on differentially 
expressed transcripts using Ingenuity Pathway Analysis (Qiagen).  The density of gene start site 
positions was quantified by performing a kernel density estimation (KDE) for each chromosome 
using the distplot function from the Seaborn v0.8.1 package for Python (www.python.org).  
Bandwidth for the KDE was set manually for chromosome 20 and scaled linearly for all other 
chromosomes based on chromosome length.  To determine whether the KDE for the 
differentially expressed transcripts was a common occurrence, a 95% percentile interval was 
constructed.  2,699 gene start sites were randomly selected (11 of which were start sites for 
identical genes) and a KDE was performed.  This process was repeated 1,000 times to obtain 
1,000 distributions.  For each point where the KDE was calculated, values were obtained for the 
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97.5th percentile and the 2.5th percentile.  These values were then used to construct an interval 
that would contain 95% of the randomly generated distributions. 
11.2.4.4. Sequencing Validation and Analysis 
Sequencing validation on genes of interest was completed with isolated RNA from additional 
blastocysts (n=12, six from each group).  Reverse transcription was performed using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and cDNA was diluted (1:4) in 1X 
Tris-EDTA buffer prior to performing quantitative reverse transcription PCR (RT-qPCR) on the 
QuantStudio 5 Real-Time PCR System (Applied Biosystems).  3ul of diluted cDNA was combined 
with 5uM primer mix and Power SYBR™ Green PCR Master Mix (Applied Biosystems) in a 15ul 
final volume and amplified under the following thermal cycling conditions:  95°C for 10 minutes 
followed by 40 cycles at 95°C for 15 seconds and 60°C for 1 minute, and a melt curve stage at 
95°C for 15 seconds, 60°C for 1 minute, and 95°C for 15 seconds.  Each sample was run in 
duplicate for 11 genes of interest (ALK, TNFRSF10A, TSPAN9, CCND3, GNAS, LTBP3, MAPK8IP1, 
NDRG1, SREBF1, EPSTI1, TLE2) and analyzed compared to the expression of three, stable, house-
keeping genes (GAPDH, PPIA, RPL19).  Statistical analysis was performed using REST 2009 
software (Qiagen) which uses PCR efficiencies and mean crossing point deviation between the 
sample and control groups to test for significance by a Pair Wise Fixed Reallocation 
Randomisation Test© (significance at P<0.05) [283].  The most consistent house-keeping gene 
was selected for normalization (PPIA). 
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11.2.5. Results 
11.2.5.1. RNA Sequencing 
RNA sequencing data was collected and an average of 46.9 million reads were acquired for each 
blastocyst.  Quality filters were applied to all samples to remove reads with poor sequencing 
quality resulting in 91% of the reads passing these filters and proceeding for alignment to the 
human reference genome.  One sample from the DC group was eliminated from further analysis 
due to poor quality.  Expression intensity was calculated using RPKM (Reads Per Kilobase of 
transcript per Million reads mapped) method and only transcripts with a mean expression of 0.05 
or greater were considered for analysis, resulting in 26,489 Ensembl IDs expressed between the 
two sample sets.  A FDR (False Discovery Rate) adjusted p-value was used to determine 
significance and reduce false positives.  Additional quality control was performed to identify and 
remove any outliers and overly abundant transcripts to reduce normalization artifact.  In total, 
2,688 (10%) of the expressed transcripts were considered significantly differentially transcribed 
in AMA blastocysts compared to DC with 2,551 of these having decreased expression (95%) and 
137 displaying increased transcription (5%) (Supplementary Table 1; Q<0.05).  When considering 
all transcripts analyzed (including those that were non-significant), 70% displayed decreased 
expression in the AMA sample set, revealing an overall global decrease in transcription in the 
blastocysts from this group.  Volcano plot analysis depicts this trend with the vast majority of 
significantly differentially expressed transcripts having a negative fold change in AMA blastocysts 
(Figure 11.2).   
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Figure 11.2: Differentially expressed transcripts in AMA blastocysts compared to donor control 
(DC).  The y-axis corresponds to the mean expression value of Log10 (Q-Value) and the x-axis 
displays the Log2 (Fold Change) value.  Red dots represent transcripts with statistically significant 
negative fold changes in AMA blastocysts (Q<0.05), whereas the green dots represent transcripts 
with statistically significant positive fold changes in AMA blastocysts (Q<0.05).  Black dots denote 
genes that were not significantly altered. 
Principal component analysis (PCA) was performed to reveal global differences between the 
sample groups.  Two distinct sets were identified using PCA, with the AMA blastocysts grouping 
together but separately from the grouped DC blastocysts, indicating uniformity and low biological 
variability among samples within each group (Figure 11.3).  Unsupervised hierarchical clustering 
analysis also distinguished the two groups, with each having uniquely different transcription 
patterns and branching separately (Figure 11.4).  The uniformity observed in the AMA blastocyst 
transcriptome reflects a strong phenotype for this sample group.  Examination of the gene 
density on individual chromosomes revealed a significantly higher number (>30%; Q<0.05) of 
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differentially expressed transcripts localized at the telomeric regions for nine chromosomes (4, 
9, 11, 16, 17, 19, 20, 21, 22) (See Supplementary Figure 1A).  Over a quarter (28%) of the 
differentially expressed transcripts in this study were found within 10 Mb of the telomeric regions 
at both chromosome ends.   
 
Figure 11.3: Principal component analysis (PCA) depicting a clear separation of AMA blastocysts 
from donor controls (DC). 
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Figure 11.4: Unsupervised hierarchical clustering of differentially expressed transcripts in AMA 
blastocysts vs. donor control (DC) showing a distinct separation between the two groups.  Red 
denotes up-regulation while blue represents down-regulation (Q<0.05). 
Canonical pathway analysis (IPA®) of the 2,688 significantly altered transcripts revealed hits for 
G-Protein Coupled Receptor Signaling, Calcium Signaling, AMPK Signaling, and Gap Junction 
Signaling, among others (Table 11.3).  Expanded Pathway Analysis of these statistically significant 
transcripts revealed a set of interacting molecular signaling networks and upstream regulators 
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important for embryo development which included SP1, ESR1, HDAC1, DMNT3B, TP53, MAPK3, 
VEGFA, and CREBBP (Figure 11.5).  A Regulator Effects analytic (IPA®) was performed to identify 
the top five upstream regulators driving the observed global decreased transcription in AMA 
blastocysts.  Altered pathways that are predicted to work with other molecules and lead to 
changes in downstream RNA expression included pathways involved in invasion, transmission 
and activation of cells, cell movement, and organismal death in blastocysts from women of 
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p-value Importance Molecules 
G-Protein Coupled 
Receptor (GPCR) Signaling 
7.41E-08 
Required for normal embryonic 
development. 
PDE6A, HTR1B, MAP2K2, ADCY5, FGFR4, HTR1E, HTR7, GRM6, IRS2, ADRA1B, PIK3C2B, PDE2A, APLNR, 
OPRM1, GR8, SSTR3, RAPGEF3, RAP1A, GRM7, RAP1GAP, PDE1B, GRM2, CAMK4, HTR4, PTGER3, 
NFKBIE, TBXA2R, CHRM4, PIK3R5, PDE4A, RAPGEF4, RGS12, HRH3, PRKAG1, OPRL1, EP300, ADRB1, 
PDE3B ,PRKCE, PIK3R2, DRD3, CAMK2B, SRC, HTR6, ADCY2, GNAS, NPY1R, ADCY6, GNAQ, OPRD1, 
GPER1, GLP1R, OPRK1, PRKCB 
Gαi Signaling 1.05E-06 Inhibits the production of cAMP from ATP. 
GRM2, PTGER3, TBXA2R, CHRM4, RGS12, HRH3, PRKAG1, GNG7, OPRL1, HTR1B, ADCY5, HTR1E, GRM6, 
DRD3, RALGDS, SRC, ADCY2, APLNR, GNAS, OPRM1, GRM8, NPY1R, SSTR3, ADCY6, RAP1A, GRM7, 
OPRD1, RAP1GAP, OPRK1 
cAMP-mediated signaling 2.34E-06 
GPCR triggered signaling cascade used in 
cell communication. 
GRM2, CAMK4, HTR4, PTGER3, CHRM4, TBXA2R, PDE4A, RAPGEF4, RGS12, HRH3, OPRL1, EP300, 
PDE6A, HTR1B, ADRB1, MAP2K2, PDE3B, ADCY5, HTR1E, HTR7, GRM6, DRD3, CAMK2B, HTR6, SRC, 
PDE2A, ADCY2, GNAS, APLNR, OPRM1, NPY1R, GRM8, SSTR3, ADCY6, RAPGEF3, RAP1A, GRM7, OPRD1, 
GPER1, RAP1GAP, GLP1R, PDE1B, OPRK1 
PKCθ Signaling in  
T Lymphocytes 
3.39E-04 
Immune response, promotes activation-
induced T cell death. 
CD247, CACNA1S, MAP3K11, HLA-A, NFKBIE, PIK3R5, HLA-DQB1, NFATC1, LCK, CACNA1E, FGFR4, IRS2, 
PIK3R2, CACNA2D3, MAP3K2, CAMK2B, PIK3C2B, CACNB1, MAP3K6, CHP1, PLCG1, CACNA1C, NFATC4, 
RAP1A, CACNA1A, VAV3, ZAP70, NFATC2, HLA-DOB 
Calcium Signaling 3.80E-04 
Increase in cytosolic Ca2+ culminates in 
the regulation of transcription factors 
including NFAT, CREB, and HDACs. Ca2+ 
signaling is associated with events during 
embryogenesis. 
CHRNA1, CACNA1S, CAMK4, TNNI2, MYL2, GRIN2D, GRIA1, TNNT2, PRKAG1, NFATC1, EP300, HDAC6, 
CACNA1E, RYR1, CACNA2D3, CAMK2B, CACNB1, CHRNA4, CHP1, CACNA1C, TNNI3, CHRNA10, NFATC4, 
CHRND, RAP1A, PNCK, CACNA1A, GRIN3A, MICU1, HDAC3, ATP2B3, CAMKK1, NFATC2, CAMKK2 
AMPK Signaling 4.47E-04 
Inhibits key enzymes of ATP consuming 
pathways and induces pathways that 
generate ATP, stimulates fatty acid 
oxidation. 
CHRNA1, RAB9B, CHRM4, PIK3R5, LIPE, CFTR, PFKL, MAPK13, CCND1, MAPK11, PRKAG1, EP300, 
ADRB1, CRTC2, TBC1D1, FGFR4, TSC2, PPM1L, IRS2, PPP2R2C, CPT1C, PIK3R2, ADRA1B, SRC, PIK3C2B, 
RAB27A, CHRNA4, ACACB, CPT1A, GNAS, AK3, CHRNA10, CHRND, FOXO6, CAMKK2 
Gap Junction Signaling 5.01E-04 
Critically important in regulating 
embryonic development. 
GRIA1, PIK3R5, NOTUM, EGF, PRKAG1, PLCE1, ADRB1, MAP2K2, ADCY5, FGFR4, TUBA3C/TUBA3D, 
PRKCE, IRS2, PIK3R2, TUBA3E, ACTG2, GJB2, MAP3K2, SRC, PIK3C2B, GJA1, ADCY2, GNAS, GUCY1A1, 
TJP1, GNAQ, ADCY6, PLCG1, PLCL2, RAP1A, GJC1, GUCY1A2, PRKCB 
Phospholipase C Signaling 5.75E-04 
Plays a role in embryonic development 
including cell migration, proliferation, and 
differentiation. 
CD247, PLD2, CAMK4, MYL2, ARHGEF1, NFATC1, GNG7, EP300, TGM2, HDAC6, LCK, IGHG3, PLCE1, 
MAP2K2, RHOD, ADCY5, PRKCE, RALGDS, SRC, ADCY2, GNAS, CHP1, ADCY6, GNAQ, PLCG1, RAPGEF3, 
NFATC4, RAP1A, PLD1, PLA2G6, PLA2G2E, HDAC3, SYK, PLA2G4B, ZAP70, NFATC2, ARHGEF10, PRKCB 
GNRH Signaling 6.31E-04 
Plays a critical role in blastocyst 
formation. 
CACNA1S, MAP3K11, CAMK4, MAPK13, MAPK11, PRKAG1, GNG7, EP300, CACNA1E, MAP2K2, ADCY5, 
PRKCE, CACNA2D3, CAMK2B, MAP3K2, SRC, CACNB1, ADCY2, GNAS, PAK6, MAP3K6, GNAQ, ADCY6, 
CACNA1C, RAP1A, CACNA1A, MAPK10, PRKCB, GNRHR 
Th1 Pathway 9.12E-04 
Th1:Th2 balance plays an important role 
in successful pregnancy maintenance and 
is associated with a decline in 
responsiveness to Th1 activation during 
aging. 
CD247, PIK3C2B, DLL1, CCR5, HLA-A, KLRD1, TYK2, PIK3R5, NFATC4, HLA-DQB1, CD8A, NFATC1, ITGB2, 
FGFR4, APH1B, NFATC2, HLA-DOB, IRS2, IL27RA, PIK3R2, JAK3, HLA-DPA1, IFNA1/IFNA13, 
ICOSLG/LOC102723996 
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Figure 11.5: Molecular signaling network predicted to be associated with the global decrease in 
transcription observed in AMA blastocysts compared to donor control (DC) blastocysts. 
11.2.5.2. Sequencing Validation 
Genes chosen for validation utilizing RT-qPCR focused on the transcription ligand-dependent 
activation of ESR1/SP/CREBBP pathway as it was observed to be a highly significant upstream 
regulator important for a variety of biological processes including cell cycle regulation, 
proliferation, and apoptosis.  In total, 62 genes regulated by the ESR1 network were found to be 
significantly decreased in AMA blastocysts, as well as 56 genes regulated by SP1, and 41 genes 
regulated by CREBBP (P<0.05).  ESR1 regulated genes chosen for validation included:  ALK, 
TNFRSF10A, and TSPAN9.  SP1 regulated genes examined for validation were:  CCND3, GNAS, 
LTBP3, MAPK8IP1, NDRG1, and SREBF1.  Finally, CREBBP regulated genes tested included:  EPSTI1 
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and TLE2.  All genes displayed a trend towards reduced expression in additional AMA blastocysts 
tested by RT-qPCR, compared to DC, confirming our observations from the RNA sequencing 
analysis (Figure 11.6).  TNFRSF10A and TSPAN9 which are regulated by ESR1, were significantly 
reduced in the blastocysts from older women (fold change = 0.63 and 0.23 respectively; P<0.05; 
Figure 11.6).  MAPK8IP1 which is regulated by SP1 was also significantly reduced in AMA 
blastocysts (fold change = 0.17; P<0.05; Figure 11.6).  EPSTI1, regulated by CREBBP was the final 
gene that displayed a significant reduction in gene expression among the AMA group (fold change 
= 0.14; P<0.05; Figure 11.6). 
 
Figure 11.6: RT-qPCR validation of genes within the ESR1/SP1/CREBBP molecular signaling 
network that displayed reduced expression in AMA blastocysts vs. donor control (DC) blastocysts.  
(*P<0.05). 
11.2.6. Discussion 
Transcriptome analysis of blastocysts from women of advanced maternal age revealed a 
significant, global down-regulation of gene expression.  This altered transcriptome could 
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implantation and live birth rates observed in this patient population, following a euploid embryo 
transfer. 
The ESR1/SP1/CREBBP pathway was predicted as a highly significant upstream regulator driving 
the observed widespread down-regulation in embryonic gene transcription associated with AMA.  
ESR1 is a ligand-activated transcription factor that can stimulate transcription directly or by 
activation of other transcription factors in a ligand-dependent manner [284].  For ESR1 to 
function, it requires the recruitment of coactivators such as SP1 which, in turn, recruit secondary 
coactivators including CREBBP that promote chromatin remodeling and facilitate the activation 
of transcription [285, 286].  Cancer studies have shown that when ESR1 is under-expressed, it 
fails to activate SP1, resulting in decreased expression of downstream genes that regulate a 
variety of processes including cell cycle regulation, proliferation and apoptosis [285].  
Furthermore, CREBBP has been previously shown to be essential for mouse embryogenesis [287]. 
The ESR1 regulated gene TNFRSF10A that displayed reduced expression with advanced maternal 
age has been implicated in the process of cellular apoptosis.  Programmed cell death plays an 
important role in gamete maturation and embryo development.  Both the inner cell mass and 
the trophectoderm have active apoptotic pathways that are required for ongoing, successful 
development.  Disruptions to the apoptotic pathway can compromise future growth and result 
in reproductive failure [288].  TSPAN9, another decreased ESR1 regulated gene in AMA 
blastocysts, plays a role in the regulation of cell development, activation, growth, and motility.  
Earlier studies have shown that TSPAN9 is localized to the plasma membrane and cytoplasm, and 
could be required for maintaining the early endosome membrane [289].  The endosome 
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functions as a signaling center for various ligand-receptor systems that have critical roles in 
embryonic patterning, particularly in the peri-gastrulation stage of embryo development [290].  
Since gastrulation occurs shortly after implantation, any signaling errors in the embryo during 
this critical time would likely negatively impact reproductive success.  A previous study utilizing 
C. elegans found that a number of tetraspanins, including TSP-21 (orthologous to human TSPAN9) 
promote BMP signaling in postembryonic development [291].  BMP has been shown to be 
important for pre-implantation development and gastrulation in mouse embryos [292].  Both 
BMP1 and BMP7 were observed in this study to be significantly reduced in expression with 
advanced maternal age.  BMP1 has also been shown to promote oocyte maturation and early 
embryo development in porcine embryos that were fertilized in vitro [293].  Several studies have 
displayed the importance of BMP7 for not only the transformation of the endometrium into a 
receptive state, but also for decidualization, and placental/embryonic development [294-296]. 
The SP1 regulated gene, MAPK8IP1, was also significantly reduced in blastocysts derived from 
AMA women.  This protein prevents MAPK8 mediated activation of transcription factors and 
plays a key role in cell signaling.  It is also involved in the JNK signaling pathway and alterations 
can induce changes to cellular physiology, including cell death [297].  The JNK pathway has been 
previously reported to be required for the 8-16 cell stage of embryonic development to the 
blastocyst stage [298].  Additionally, Thompson et al. found that targeted disruption of Mapk8ip1 
in the mouse embryo resulted in embryonic death prior to blastocyst implantation [299]. 
The CREBBP regulated gene, EPSTI1, is known to promote tumor invasion and metastasis.  While 
widely known for its role in invasive breast carcinomas, this gene has also been found to be crucial 
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in endometrial remodeling prior to embryo attachment [300].  The trophoblast cells of an early 
embryo rapidly proliferate and attempt to invade the endometrial decidua, later proliferating 
and migrating into the uterine wall to anchor the placenta [301].  These actions are 
extraordinarily similar to cancer cells with their capacity for proliferation and migration [301].  
The reduced expression observed in EPSTI1 with advanced maternal age is therefore likely to not 
only reduce the ability of the pre-implantation embryo to proliferate and invade the 
endometrium, but also hinder the molecular cross-talk at the fetal-maternal interface, thereby 
preventing implantation. 
The overall global decrease in transcription observed in AMA blastocysts also impacted 
chromatin structure with two histone deacetylase genes shown to have reduced transcription 
(HDAC3 and HDAC6).  The HDAC family plays a critical role in development by modulating 
chromatin structure involved in DNA replication, repair, and gene transcription [302].  Reduced 
expression would lead to chromatin relaxation which can promote DNA damage and result in 
genomic instability [303].  Hdac3 is a key regulator of chromatin structure and inactivation 
triggers apoptosis in mice [304].   Additionally, Montgomery et al. found that mutant mice with 
a global deletion of Hdac3 resulted in early embryo lethality [305].  Hdac6 has been previously 
reported to be localized in the cytoplasm of germinal vesicle stage oocytes and 1-cell embryos in 
mice and its ectopic expression causes premature compaction of chromatin [306]. 
Telomeres are specialized non-coding DNA sequences located at the ends of all chromosomes 
that protect these regions from recombination and degradation activities as well as serve to 
maintain chromosome integrity [307, 308].  Telomeres shorten as a function of aging due to 
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decreased telomerase activity leading to DNA damage that causes replicative senescence [309].  
Telomerase activity is absent in most adult human tissues due to the lack of expression of TERT 
that is expressed in developing embryos [310, 311].  TERT expression was significantly reduced 
in the blastocysts from AMA women in this study, indicating reduced telomerase activity and 
possibly a shortening of the telomeres in this aged patient population.  Telomere shortening has 
been shown to cause widespread changes in the transcription of genes located up to 10 Mb from 
a telomere in human myoblasts which could explain the high proportion of significant 
differentially expressed genes located in the sub-telomeric regions of AMA blastocysts [309]. 
Similarities were observed between this study and the publication by Kawai et al. who 
investigated gene expression profiles in human blastocysts relative to parental age (31-41 years 
of age) [278].  Several, common, down-regulated genes were involved in cell growth, 
differentiation, and proliferation including PCBP4, PPP2R2C, MYO16, and PTPRD.  Others were 
linked to oxidative damage, cell stress, and the inflammatory response which included MSRA, 
FAAP24, MICU1, and AOAH.  TLE6 was also down-regulated in both studies and has additionally 
been reported to be reduced in the trophectoderm cells from non-implanting embryos [312].  
These similarities reinforce my findings that blastocysts from women of advanced maternal age 
are being impacted on a cell signaling level to repress the embryo’s ability to proliferate and 
implant.   
At the time of publication, this was the first study utilizing total RNA sequencing technology to 
examine, specifically, the impact of advanced maternal age (≥42 years) on pre-implantation 
embryonic development directly compared to young, donor controls, highlighting the molecular 
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changes that occur in the AMA patient.  An overall compromised global transcriptome was 
observed in maternally aged blastocysts impacting transcriptional regulators and their biological 
pathways including cell growth, invasion, and an increased probability for organismal death, 
among others.  These results provide molecular evidence of compromised embryo development 
with advanced maternal age, explaining the deterioration of reproductive outcomes for this 
patient population, independent of chromosome constitution. 
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11.3. Specific Aim 3 
To test the hypothesis that methylation alterations explain differing implantation potential 
among aneuploid blastocysts in correlation with chromosome constitution. 
The following published work is presented for this specific aim: 
BR McCallie, JC Parks, AL Patton, DK Griffin, WB Schoolcraft, MG Katz-Jaffe. Hypomethylation 
and Genetic Instability in Monosomic Blastocysts May Contribute to Decreased Implantation 
Potential.  PLoS One. 2016 Jul 19;11(7):e0159507. 
 
11.3.1. My Personal Contribution to the Work 
For this study, I lysed and bisulfite converted the DNA.  I also performed all of the primer design, 
RNA isolation, reverse transcription, and real-time PCR including the corresponding analyses.  
Additionally, I wrote and edited the manuscript. 
11.3.2. Chapter Summary 
The aim of this study was to determine if DNA methylation is associated with chromosomal 
aneuploidy in human blastocysts and if these epigenetic marks are leading to downstream 
genetic instability that contribute to decreased implantation potential.  Surplus, cryopreserved 
blastocysts that were donated to research with IRB consent were chosen with varying 
chromosomal aneuploidies and respective implantation potential: monosomies and trisomies 7, 
11, 15, 21, and 22.  DNA methylation analysis was performed using the Illumina Infinium 
HumanMethylation450 BeadChip (~485,000 CpG sites).  The methylation profiles of these human 
blastocysts were found to be similar across all samples, independent of chromosome 
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constitution; however, more detailed examination identified significant hypomethylation in the 
chromosome involved in the monosomy.  Real-time PCR was also performed to determine if 
downstream messenger RNA (mRNA) was affected for genes on the monosomy chromosome.  
Gene dysregulation was observed for monosomic blastocysts within significant regions of 
hypomethylation (AVEN, CYFIP1, FAM189A1, MYO9A, ADM2, PACSIN2, PARVB, and PIWIL3).  
Additional analysis was performed to examine the gene expression profiles of associated 
methylation regulators including: DNA methyltransferases (DNMT1, DNMT3A, DNMT3B, 
DNMT3L), chromatin modifying regulators (CSNK1E, KDM1, PRKCA), and a post-translational 
modifier (PRMT5).  Decreased RNA transcription was confirmed for each DNMT, and the 
regulators that impact DNMT activity, for only monosomic blastocysts.  
11.3.3. Introduction 
During reproduction, an embryo receives one set of chromosomes from the sperm, and one set 
from the oocyte, resulting in a complete set of 23 chromosome pairs.  Errors during meiotic or 
mitotic cell division can lead to extra or missing chromosomes, termed aneuploidy, which is the 
leading cause of miscarriage, stillbirth, and congenital birth defects [313].  The most significant 
risk factor for an aneuploid conception is advanced maternal age.  In fact, 35-50% of oocytes from 
women aged 35-39 will have chromosomal aneuploidies and this will climb to over 80% once a 
woman reaches 45 years of age [314].  Aneuploidy can occur for any chromosome with the 
highest proportion observed in conception belonging to the smaller sized chromosomes (15-22) 
[315].  Only a fraction of full aneuploidies, specifically trisomies 13, 18, 21, XXY, and XYY, will 
develop past the first trimester and may even result in a live birth [316].  Nevertheless, even the 
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vast majority (>95%) of these trisomies will perish in utero.  This is in contrast to full monosomies 
which almost never implant or result in an ongoing pregnancy.  Turner syndrome (XO) is the only 
exception and the only full monosomy known to reach term.  Partial fetal autosomal monosomies 
are observed during clinical pregnancy, where only a portion of a chromosome is missing, and 
these imbalances can lead to various phenotypes depending on the chromosome involved, the 
size of the absent chromosome, and which genes are impacted [317].   
DNA methylation is a biochemical process that plays an important role in regulating gene 
expression without altering the underlying DNA sequence and involves the addition of a methyl 
group to a cytosine in a CpG dinucleotide.  This is established either de novo, by DNA 
methyltransferases DNMT3A, DNMT3B, and DNMT3L, or during replication by the maintenance 
methyltransferase DNMT1 [318].   Appropriate methylation is essential for both normal cell 
differentiation and development [319, 320].  Methylation is involved in chromatin structure 
which is responsible for proper chromosome segregation during cell division as well as regulating 
gene expression [321]. Global epigenetic reprogramming begins in the early embryo with DNA 
demethylation occurring post fertilization through to the blastocyst stage.  This process is 
essential for the establishment of embryonic gene expression patterns during re-methylation 
which is required for implantation and ongoing fetal development [320].  Only imprinted genes 
escape demethylation to preserve their exclusive parent-of-origin-specific gene expression 
profiles [216].  DNA methylation is also shown to be vital in the maintenance of X chromosome 
inactivation which is crucial for female embryos due to the presence of two X chromosomes 
[322].  It is well known that disturbances during these methylation processes can result in 
developmental delays and/or embryo death.  Loss of Dnmt1 activity results in significantly lower 
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DNA methylation levels, as well as impaired implantation and embryo development in mice [323].  
Dnmt3a mutant mice develop to term but are runted and die at around four weeks of age while 
Dnmt3b mutant mice have no viable births as their embryos are found to have multiple 
developmental defects [97].  Dnmt3l interacts with Dnmt3a and 3b and has been shown in mice 
to play an important role in the regulation of genomic imprinting and embryonic development 
[324]. 
Given the importance of DNA methylation and chromosome constitution to healthy 
fetal/embryonic development, the aim of this study was to investigate the association between 
methylation, the molecular processes involved in establishing methylation, and chromosomal 
aneuploidies.  Results revealed that trisomic blastocysts had similar methylation profiles to their 
euploid counterparts.  In contrast, monosomic blastocysts were hypomethylated for the 
chromosome involved in the error and displayed altered expression of developmental genes and 
DNMTs, which could be contributing to their overall compromised implantation potential. 
11.3.4. Methods and Materials 
11.3.4.1. Blastocysts 
Surplus, cryopreserved blastocysts (n=316) from the Colorado Center for Reproductive Medicine 
were donated for research with written IRB consent, including blastocysts donated from donor 
oocyte cycles.  This study was approved by HCA-HealthONE (study #231587) and Western 
Institutional Review Board (study #1145350).  All blastocysts were viable and morphologically 
similar, graded as high quality expanded blastocysts (≥ 3BB) on day 5 of embryonic development 
using the Gardner and Schoolcraft system [247].  Blastocysts underwent trophectoderm biopsy 
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for comprehensive chromosome screening prior to vitrification using the cryotop method as 
previously described [325].  The control group consisted of euploid, day 5 blastocysts produced 
from donor oocyte IVF cycles with no male factor infertility.  Specific aneuploidies were chosen 
based on their differing implantation potential and included chromosomes 7, 11, 15, 21, and 22. 
Trisomies 7 and 11 are most likely to result in implantation failure; trisomies 15 and 22 are able 
to implant however will always result in miscarriage; and trisomy 21 embryos will implant but 
result in either miscarriage, still birth, or live birth.   
11.3.4.2. DNA Lysis and Methylation Analysis 
After warming, blastocysts (n=230) were lysed using the EZ DNA Methylation-Direct™ Kit (Zymo 
Research, Irvine CA).  Briefly, pools of 10 re-expanded blastocysts, with 2-3 biological replicates 
per group, were washed through a series of PBS washes before being lysed in a digestion buffer 
containing 20ug Proteinase K in a 20ul final volume.  Samples were incubated at 50°C for 20 
minutes and then stored at -80°C.  All 20ul of each sample were bisulfite converted by adding 
130ul of CT Conversion Reagent and incubated at 98°C for 8 minutes and 64°C for 3.5 hours.  
Samples were then purified on the Zymo-Spin™ IC Column according to manufacturer’s protocol 
and eluted in 10ul of M-Elution Buffer.  500ng of each sample were amplified, fragmented, and 
hybridized to the Infinium HumanMethylation450K BeadChip (Illumina, San Diego CA).  
GenomeStudio Methylation Module 1.0 software (Illumina) was used for image processing and 
to perform normalization and differential methylation analysis.  Normalization was performed 
using both normalization control probes as well as background subtraction.  Methylation beta 
values were then determined for each sample which estimate the methylation level of the CpG 
locus using the ratio intensities between methylated and unmethylated alleles.  A value of “0” 
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represents no methylation and a value of “1” indicates full methylation.  DiffScore was calculated 
using the Illumina Custom Model to determine significance at P < 0.05.  Variance was estimated 
across replicate samples. 
11.3.4.3. RNA Isolation, Reverse Transcription, and Real-Time PCR 
RNA was either isolated using the PicoPure RNA Isolation Kit (Life Technologies, Grand Island, NY) 
or lysed and deoxyribonuclease treated using the Taqman® Gene Expression Cells-to-Ct™ Kit (Life 
Technologies).  For primer-based assays, warmed blastocysts (n=50) were washed through ice-
cold PBS containing bovine serum albumin (BSA) prior to being transferred into 10ul of Extraction 
Buffer.  RNA was then purified from individual blastocysts (PicoPure) according to manufacturer’s 
protocol with minor modifications [326].  RNA quantity and quality were assessed using the 
NanoDrop® Spectrophotometer ND-1000 (Thermo Scientific, Wilmington DE) before being 
reverse transcribed using the High Capacity cDNA Archive Kit (Life Technologies) where 20ul of a 
master mix was combined with all 20ul of the purified RNA and incubated according to protocol. 
For Taqman® assays, warmed blastocysts (n=36) were washed as previously mentioned prior to 
being individually transferred into 10ul of Lysis Solution containing DNase I (Cells-to-Ct™) and 
incubated at room temperature for 8 minutes.  1ul of Stop Solution was added to each sample 
and incubated at room temperature for 2 minutes.  Samples were reverse transcribed with 30ul 
of master mix and 10ul of RNA lysate.  cDNA was then amplified by using 37.5ul of Taqman® 
PreAmp Master Mix containing 0.05X of each Taqman® probe with 12.5ul of the cDNA under the 
following thermal cycling conditions:  95°C for 10 minutes and 12 cycles at 95°C for 15 seconds 
and 60°C for 4 minutes.   
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Primer-based quantitative real-time PCR was performed using the ABI 7300  Real-Time PCR 
System (Life Technologies) by combining 5ul of diluted cDNA (1:4) with 7ul water, 12.5ul SYBR 
Green PCR Master Mix (Life Technologies) and 0.5ul of 5uM primer pool.  After a 10 minute 
incubation at 95°C, amplification occurred for 40 cycles at 95°C for 15 seconds and 60°C for 1 
minute, followed by a dissociation stage.  Standard curves were calculated for each gene by 
performing 10-fold serial dilutions of reference RNA (Agilent, Santa Clara CA).  Expression of 8 
genes of interest were analyzed in duplicates (AVEN, CYFIP1, FAM189A1, MYO9A, ADM2, 
PACSIN2, PARVB, and PIWIL3) relative to an internal house-keeping gene, PPIA, which had the 
most consistent expression across all samples (Table 11.4).  Negative controls were performed 
for each gene and all remained unamplified with Ct values at 40. 
Taqman® qPCR was performed by combining 4ul of diluted pre-amplified product (1:5) with 5ul 
nuclease-free water, 10ul Taqman® Gene Expression Master Mix, and 1ul Taqman® probe.  This 
was run on the ABI7900HT Fast Real-Time PCR System (Life Technologies) at 95°C for 10 minutes, 
and 40 cycles at 95°C for 15 seconds and 60°C for 1 minute.  Standard curves were calculated as 
previously described and expression of eight genes of interest were analyzed in duplicates 
(DNMT1, DNMT3A, DNMT3B, DNMT3L, CSNK1E, KDM1, PRKCA, and PRMT5) relative to an 
internal house-keeping gene, RPL19, which had the most consistent expression across all samples 
(Table 11.5).  Negative controls were also performed for each Taqman® assay and all were found 
to be unamplified. 
Data normalization and analysis were performed using REST 2009 software (Qiagen, Valencia CA).  
REST software uses the correction for exact PCR efficiencies with mean crossing point deviations 
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between sample and control groups to determine an expression ratio that is tested for 
significance by a Pair Wise Fixed Reallocation Randomization Test.  Significance was defined as P 
< 0.05.
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Table 11.4: Primer information and qPCR efficiencies for chromosomes 15, 22, and house-keeping genes. 





Chromosome Primer Sequence (3’-5’) 





15 F: AAGAGCTGGAAGACTGGTTGGA 
R: TATGCCCACCTGCCGTTAG 





15 F: ACGACCACTCAGCGTACAAGAG 
R: TCTGCGATTCCTGGATGGA 





15 F: GGGACACCCAGGATGATCTG 
R: GGAAATGCAATCCCCAAAGAG 





15 F: CAATACACTGGAACGCCTCATC 
R: ACACAATGGCCAAAGCATTAGC 





22 F: GAGCCTAAACACCCTGAAATTGTG  
R: TCTCTGAAGCGCTTAGCATCTG 





22 F: AAGCCCTGGGCCAAGAAG 
R: GCTGCATGGTGGGCTTTC 





22 F: TCTCTGGCCATGCACTTCAG 
R: ACCACCACCTGCACCGTTAC 





22 F: AAAGAGCGGAGAGTGGAATGG 
R: ACGTGGGCGTGAGTTCTTTG 
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Table 11.5: Genes involved in DNA methylation processes (including two house-keeping genes) and qPCR efficiency information 
(Taqman® assays; Life Technologies). 




DNMT1 1786 / Hs00154749_m1 -3.46 
27.92 
0.99 
19 Maintenance methyltransferase 
DNMT3A 1788 / Hs01027166_m1 -3.48 
31.02 
0.99 
2 de novo methlytransferase 
DNMT3B 1789 / Hs00171876_m1 -3.35 
29.97 
0.99 
20 de novo methlytransferase 
DMNT3L 2994 / Hs01081364_m1 -2.73 
34.00 
0.95 
21 In-active methyltransferase essential for the function of DNMT3A and DNMT3B 
CSNK1E 1454 / Hs00266431_m1 -3.95 
28.02 
0.99 
22 Post-translational regulation 
KDM1 23028 / Hs01002741_m1 -3.76 
29.90 
0.99 
1 Post-translational regulation 
PRKCA 5578 / Hs00925193_m1 -4.13 
30.52 
0.97 
17 Post-translational regulation 
PRMT5 10419 / Hs01047356_m1 -3.77 
29.17 
0.99 
14 Chromatin modifying protein 
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11.3.5. Results 
11.3.5.1. Global Methylation Analysis 
Analysis of the blastocyst methylome for monosomies 7, 11, 15, 21, and 22, as well as 
trisomies 7, 11, 15, 21, and 22, compared to control blastocysts, was performed using the 
Illumina Infinium HumanMethylation450K BeadChip.  To avoid bias, groups were blinded 
and Illumina GenomeStudio Software was used for normalization, beta value calculations, 
and DiffScore determination.  When analyzing the overall methylation profiles of any 
blastocyst group, no significant differences were observed regardless of chromosome 
constitution.  The average beta value (0 = no methylation, 1 = full methylation) for each 
group was similar, ranging from 0.20 to 0.21, representing an overall hypomethylated 
state (Table 11.6).  For comparison, a typical somatic cell has a beta value of around 0.5 
[327].  Further examination of the methylome of each individual chromosome revealed 
all trisomic blastocysts, independent of which chromosome had a third copy (7, 11, 15, 
21, or 22), were similar to the diploid state (Table 11.7).  For example, the beta value of 
chromosome 11 in trisomy 11 blastocysts was 0.21 (Table 11.7, column D) and the beta 
value of chromosome 11 in control blastocysts was 0.22 (Table 11.7, column A).  In 
contrast, all monosomic blastocysts showed a decreased methylated state for the specific 
missing chromosome in comparison to controls.  In this case, monosomy 11 blastocysts 
displayed significant hypomethylation of chromosome 11 with a beta value of 0.17 (Table 
11.7,   column E, P < 0.05) compared to chromosome 11 in either trisomic or control 
blastocysts which had beta values of 0.21 and 0.22 respectively.  All other correctly-paired 
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chromosomes from these aneuploid blastocysts displayed a methylation profile similar to 
control blastocysts (Table 11.7). 
Table 11.6: Methylome profiles of pooled human blastocysts (n = 10 each pool with 2–3 
replicates per group).  Beta value reflects the level of global methylation with no variation 
observed in association with blastocyst chromosome constitution. (no statistical 
significance).  Standard deviation (STDEV) was calculated for each group, reflecting low 
biological variability between replicates. 
Group Beta Value 
(Avg) 
STDEV 
Diploid (Euploid) 0.21 0.01 
Trisomy 7 0.21 0.01 
Trisomy 11 0.20 0.01 
Trisomy 15 0.20 0.01 
Trisomy 21 0.20 0.01 
Trisomy 22 0.20 0.01 
Monosomy 7 0.20 0.01 
Monosomy 11 0.20 0.06 
Monosomy 15 0.20 0.00 
Monosomy 21 0.20 0.01 
Monosomy 22 0.21 0.00 
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Table 11.7: Methylation profiles of individual chromosomes for blastocysts with a specific 
chromosome constitution (red font indicates P < 0.05). 
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11.3.5.2. Blastocyst Gene Expression 
mRNA analysis was performed on individual blastocysts that were monosomy or trisomy for 
chromosome 15, monosomy or trisomy for chromosome 22, and controls for key developmental 
genes located in cytoband regions with significantly altered methylation.  The chromosome 15 
genes AVEN (15q13.1), CYFIP1 (15q11), FAM189A1 (15q13.1) and MYO9A (15q22-q23) were all 
determined to have reduced expression in monosomy 15 blastocysts compared to control 
blastocysts (P < 0.05; Figure 11.7A).  In contrast, trisomy 15 blastocysts had similar expression 
profiles to controls (ns).  Chromosome 22 genes ADM2 (22q13.33), PACSIN2 (22q13.2-q13.33), 
PARVB (22q13.2-q13.33), and PIWIL3 (22q11.23) were all shown to have significantly lower 
expression levels in monosomy 22 blastocysts compared to controls (P < 0.05; Figure 11.7B) with 
trisomy 22 blastocysts displaying no significant differences.  All samples were normalized to the 
house-keeping gene, PPIA, which had stable expression within all sample groups. 
  







Figure 11.7: Developmental gene expression in individual human blastocysts (n = 10 replicates 
for each group) was performed by qPCR.  Ct values were normalized to PPIA, an internal, 
constant house-keeping gene.  Fold change was determined using the ΔΔCt method on the 
average of technical duplicates.  Error bars represent standard error and the y-axis denotes fold 
change between euploid and aneuploid.  (a)  Significant decreased expression of chromosome 
15 genes in monosomy 15 blastocysts compared to controls (*P < 0.05).  (b)  Significant 
decreased expression of chromosome 22 genes in monosomy 22 blastocysts compared to 
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Gene expression analysis was also examined on additional, individual blastocysts for DNA 
methyltransferases and regulatory genes associated with establishing methylation.  Monosomy 
15 and trisomy 15 blastocysts were analyzed alongside controls for the following genes:  DNMT1, 
DNMT3A, DNMT3B, DNMT3L, CSNK1E, KDM1, PRKCA, and PRMT5.  It is important to note that 
none of these genes are located on chromosome 15 to avoid expression bias in these aneuploid 
samples.  RPL19 was used as the internal house-keeping gene and had constant, stable expression 
in all sample groups.  All 4 DNA methyltransferases showed decreased expression in monosomy 
15 blastocysts compared to controls (Figure 11.8A) with DNMT1, DNMT3B, and DNMT3L being 
statistically significant (P < 0.05).  DNMT1 showed the largest difference with a nearly 10-fold 
decrease in expression observed in the monosomy 15 blastocysts.  Post-translational regulatory 
genes responsible for the regulation of DNMT1 gene expression (CSNK1E, KDM1, and PRKCA) 
revealed reduced expression in monosomy 15 blastocysts compared to controls (Figure 11.8B) 
with CSNK1E, PRKCA, and showing statistical significance (P < 0.05).  The chromatin modifying 
protein, PRMT5, also displayed significantly decreased expression in monosomy 15 blastocysts (P 
< 0.05; Figure 11.8B).  No expression differences were calculated to be statistically significant for 











Figure 11.8: Epigenetic regulator expression in individual human blastocysts by qPCR (n = 12 
replicates for each group).  Ct values were normalized to RPL19, an internal, constant house-
keeping gene.  Fold change was determined using the ΔΔCt method on the average of technical 
duplicates.  Error bars represent standard error and the y-axis denotes fold change between 
euploid and aneuploid.  (a)  The expression of DNA methyltransferases was analyzed in euploid, 
trisomy 15, and monosomy 15 blastocysts (*P < 0.05).  (b)  The expression of post-translational 
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11.3.6. Discussion 
Chromosome segregation errors during maternal or paternal meiosis that lead to aneuploidy in 
the resulting embryo are well documented in human reproduction.  While a handful of trisomic 
embryos (chromosomes 13, 18, 21, X and Y) can result in ongoing clinical pregnancies, 
monosomic embryos are rarely observed post-implantation, with Turner syndrome being the 
only exception [328].  The bias against implantation of autosomal monosomies indicates that the 
lack of an autosomal chromosome is critical for development.  This study investigated the 
relationship between chromosome aneuploidy, epigenetic mechanisms, and gene transcription 
as possible mechanisms to explain the low implantation potential of monosomic embryos. 
Mammalian embryos undergo active and passive global demethylation, following fertilization, 
which reaches minimum levels at the morula/blastocyst stage.  Therefore, unlike somatic cells 
with 50% methylation, the methylation status of a human blastocyst is significantly reduced 
[329].  Our results revealed a similar hypomethylated state of human blastocysts, independent 
of the blastocysts’ chromosome constitution (monosomy, trisomy, or diploid).  Closer 
examination of the methylation profile of each individual chromosome revealed reduced 
methylation on the chromosome involved in the error for monosomic blastocysts.  This could be 
reflective of the presence of only a single chromosome from the pair of chromosomes.  In 
contrast, no methylation differences were observed between trisomic blastocysts and diploid 
controls, including for the extra chromosome involved in the aneuploidy.  This observation could 
reflect dosage alterations of the trisomic blastocyst to normalize its transcriptome in order to 
offset the presence of the third chromosome [330].  In fact, evidence of this has been reported 
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in studies of Down syndrome that have shown tissue specific differences in the transcript levels 
of chromosome 21 genes [331, 332].  While there were genes that displayed an expected 50% 
increase in transcription, others exhibited no expression differences, and in some cases, even 
decreased expression was observed [331].  Transcriptional regulation in response to gene copy 
number for specific cell types could be the mechanism responsible for the observed gene dosage 
compensation [331].  Specifically, it has been suggested that stimulating mRNA degradation 
could be the active mechanism that allows for post-transcriptional buffering of aneuploidy in 
trisomic cells [333]. 
To determine if the methylation changes observed on the chromosome associated with the error 
were disrupting gene transcription, mRNA analysis was performed on key developmental genes.  
AVEN, CYFIP1, FAM189A1, and MYO9A are located within specific cytogenetic regions of 
chromosome 15 that displayed the most substantial levels of hypomethylation in monosomy 15 
blastocysts.  Transcriptional analysis revealed significant reduction in expression compared to 
controls for these developmental genes.  AVEN plays an important role in male and female germ 
cell development and has been shown to induce apoptosis in cells that have large amounts of 
DNA damage [334].  Reduced expression would diminish the apoptotic activity required to 
prevent abnormal cells from further development, thereby allowing these monosomic embryos 
to progress further than they should, forcing their demise prior to implantation.  CYFIP1 is 
involved in mRNA translation and knockout mouse embryos have been shown to be significantly 
reduced in size, developmentally delayed, and do not survive past the blastocyst stage [335, 336].  
This has important implications for monosomic embryos.  Although they can grow to the 
blastocyst stage and appear to be of good quality, suitable expression levels of CYFIP1 are 
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essential for further embryonic development and proper implantation.  FAM189A1 is a CD20-like 
multi-pass transmembrane protein that is required for cell signaling [337].  These proteins are 
expressed on the surface of B-cells which are important for antibody response.  With pregnancy 
being a pro-inflammatory state, proper expression of these proteins would be required for 
successful implantation to occur.   MYO9A mutations are known to cause several diseases in 
humans [338].  This gene is a class IX myosin molecule that is important for epithelial formation 
and down-regulation of MYO9A has been shown to affect cell morphology and differentiation 
[339].  Complete knockdown disrupts the formation and stabilization of cell-to-cell contacts 
during early development.  Reduced expression of MYO9A could be greatly impacting the ability 
of monosomic blastocysts to have functional interactions with the uterus, thereby reducing the 
ability to implant and develop into a viable pregnancy.   
ADM2, PACSIN2, PARVB, and PIWIL3 are located within highly significant hypomethylated 
cytogenetic regions of chromosome 22 and were all found to have significantly lower expression 
in monosomy 22 blastocysts compared to controls.  ADM2 is an invasion promoting peptide that 
regulates placental mucin 1 (MUC1) and plays an important role in embryo implantation by 
promoting placental growth and inhibiting MUC1 expression in order to assist in trophoblast 
invasion [340].  PACSIN2 plays a role in endocytosis [341] and cell migration [342].  Decreases in 
PACSIN2 expression have been postulated to result in unregulated activation of ɑ5β1 integrin 
which would reduce the ability of mesodermal cells to migrate [343].  This would have a very 
severe impact on the ability of a monosomic embryo to implant.  PARVB is involved in cell 
adhesion and survival and also plays an important role in angiogenesis which promotes tumor 
growth in cancers [344-346].  The biology of tumor development and progression is similar to 
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that of trophoblast invasion required for implantation.  Reduced expression would prevent these 
cells from sufficiently being able to invade the maternal uterus.  Likewise, PIWI genes are mainly 
expressed in germ cells and their proteins participate in germ cell differentiation with 
overexpression leading to malignancy [346].  PIWIL3, specifically, is required for early mammalian 
oogenesis and embryogenesis [347] and the under expression observed in monosomic 
blastocysts, again, could prevent trophoblast invasion leading to failed implantation.   
Each of these developmental genes on chromosomes 15 and 22 displayed, roughly, a 0.5-fold 
expression decrease in monosomic blastocysts and could be contributing to their overall reduced 
competence and lack of implantation potential.  Gene dosage is likely a contributing factor for 
this reduced expression, with the presence of only a single chromosome from the pair of 
chromosomes.  In contrast, the transcription levels for each of the developmental genes in 
trisomy 15 and trisomy 22 blastocysts remained unchanged compared to controls.  This indicates 
transcriptional compensation by trisomic embryos, away from the expected 1.5-fold increase, 
which could explain their future implantation potential. 
Additional mRNA analysis was performed to determine if the processes involved in establishing 
methylation are impacted in monosomic blastocysts.  DNA methyltransferases are the enzymes 
responsible for DNA methylation acquisition and maintenance during embryogenesis.  DNMT1 is 
the maintenance methyltransferase that replicates methylation patterns on daughter DNA 
strands during mitosis [79].  DNMT3A, 3B, and 3L are de novo methyltransferases that set up DNA 
methylation patterns early in embryonic development, initiating at the blastocyst stage, and are 
also required for establishing maternal genomic imprints in gametes [324].  DNMT1, DNMT3B, 
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and DNMT3L all displayed significantly reduced expression in monosomic blastocysts compared 
to either controls or trisomic blastocysts. 
Reduced transcription was also observed in monosomic blastocysts for two post-translational 
regulatory genes, CSNK1E and PRKCA, which are required for DNMT1 activity.  These two genes 
showed no differences when comparing expression profiles between trisomic blastocysts and 
controls.  Furthermore, reduced gene expression was confirmed only in monosomic blastocysts 
for a chromatin modifying protein, PRMT5, which is recruited along with the DNMTs, to remodel 
histones through arginine methylation, resulting in the silencing of genes [348].  PRMT5 has been 
shown to be required throughout the resetting of the epigenome, during pre-implantation 
development [349].  These combined mRNA expression data in monosomic blastocysts compared 
to trisomic or controls suggest that a decrease in the functionality of DNMT machinery may result 
during cell division and DNA replication due to the presence of only a single chromosome from 
the pair, thereby compromising further development. 
In conclusion, this novel study revealed hypomethylation of the chromosome involved in the 
error for monosomic blastocysts, alongside decreased expression of developmental genes 
located on the chromosome of error and altered transcription of DNA methylation processes.  
Taken together, the altered methylation and disrupted downstream transcription could be 
directly impacting the developmental and implantation potential of monosomic blastocysts as it 
is well known that the autosomal monosomy state of a whole chromosome is not well tolerated 
during the window of implantation.  In contrast, the trisomic blastocyst displays transcriptional 
dosage compensatory mechanisms for the presence of an additional chromosome, revealing 
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similar methylation and gene expression to controls, and thereby giving an explanation for the 
difference in the implantation potential between trisomic and monosomic embryos.  Future 
studies investigating epigenetic mechanisms associated with chromosome constitution may 
further expand our knowledge of human chromosomal aneuploidy and increase our 
understanding of its origins and impact during the window of implantation.  
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11.4. Specific Aim 4 
To establish whether underlying infertility diagnoses (polycystic ovaries, male factor, and 
unexplained) have an impact on the transcriptome of developing blastocysts. 
The following published work is presented for this specific aim: 
BR McCallie, JC Parks, DK Griffin, WB Schoolcraft, MG Katz-Jaffe.  Infertility Diagnosis has a 
Significant Impact on the Transcriptome of Developing Blastocysts.  Mol Hum Reprod. 2017 Aug 
1;23(8):549-556. 
11.4.1. My Personal Contribution to the Work 
For this study I designed the primers and performed all of the RNA isolation, microarray 
experiments, reverse transcription, and quantitative real-time PCR and analysis.  I also wrote and 
edited the manuscript. 
11.4.2. Chapter Summary 
The objective of this study was to characterize the global transcriptome of human blastocysts, 
from patients presenting with specific infertility etiologies, to elucidate novel biological pathways 
that may influence downstream implantation.  Surplus cryopreserved blastocysts from female 
patients who were <38 years old with male patients <40 years old were donated to research with 
IRB consent.  Blastocysts were grouped according to infertility diagnosis:  polycystic ovaries, male 
factor, unexplained, and fertile donor oocyte controls.  Pooled blastocysts were lysed for RNA 
isolation followed by microarray analysis.  Validation was performed on significant genes of 
interest using RT-qPCR.  Transcription alterations were observed for all infertility etiologies 
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compared to controls, resulting in differentially expressed genes:  PCO=869, MF=348, and 
UE=473.  Functional annotation of biological and molecular processes revealed both similarities, 
as well as differences, across the infertility groups.  All infertility etiologies displayed 
transcriptome alterations in signal transducer activity, receptor binding, reproduction, cell 
adhesion, and response to stimulus.  Blastocysts from PCO patients were also enriched for 
apoptotic genes while MF blastocysts displayed enrichment for genes involved in cancer 
processes.  Blastocysts from couples with unexplained infertility displayed transcription 
alterations related to various disease states which included mTOR and adipocytokine signaling.  
RT-qPCR validation confirmed differential gene expression for the following genes:  BCL2L10, 
HSPA1A, HSPA1B, ATF3, FGF9, LEFTY1, LEFTY2, GDF15, INHBA, AJAP1, CDH9, and LAMA4.   
11.4.3. Introduction 
The World Health Organization (WHO) estimates that one out of six couples struggle with 
infertility and the origins are equally distributed between male and female.  There are many 
different causes of infertility including, among others, polycystic ovaries (PCO) and male factor 
(MF).  Infertility can be the result of a variety of problems including genetic and hormonal.  When 
all known sources have been ruled out, the couple is defined as idiopathic or unexplained.   
Polycystic ovarian syndrome is the most common endocrine disorder in women of reproductive 
age and is the result of hormonal imbalances, which lead to rare or irregular ovulation [8, 9].  
Unlike PCOS, women diagnosed with polycystic ovaries do not have a metabolic condition but 
have ovaries with abnormally high follicle counts.  PCO is far more common than PCOS and these 
patients often have poorer quality oocytes and embryos [6, 7]. 
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Male factor infertility, which is almost always defined as abnormal semen analysis based on WHO 
guidelines, is solely responsible for 20-30% of human infertility and is a contributing factor in half 
of all couples presenting for ART [4].  Problems with sperm production can originate from many 
different factors and have been shown to result in delayed and failed fertilization, as well as 
compromised embryo development and quality [350, 351]. 
Unexplained infertility is diagnosed in about 15-30% of infertile couples [5].  These patients can 
present with varying infertility histories including multiple IVF failures, poor embryo 
development, as well as lengthy periods of infertility.  A retrospective review of 45 studies found 
that couples with this diagnosis have, on average, a 1-4% chance of achieving pregnancy during 
any given menstrual cycle without utilizing ART [352].  Nevertheless, 40-60% will spontaneously 
conceive within three years (depending on the female partner’s age) and this rate can increase 
to as high as 75% with the use of ART [353].  ART techniques can also potentially help further 
address the cause of infertility in these patients (i.e. low fertilization rates, embryo 
fragmentation, abnormal oocytes, etc.) as well as improve time to conception. 
A fertilized oocyte must not only facilitate the syngamy of the male and female genomic 
contributions but also undergo a series of cellular divisions before embryonic genome activation 
is initiated [354].  Both the timing of the activation, as well as the synchrony of genes activated, 
must be accurately controlled to produce a blastocyst stage embryo that is viable and 
developmentally competent for implantation to occur [355].  In the mouse model, studies have 
observed two waves of embryonic gene transcription, the first corresponding to zygotic genome 
activation which occurs at the 1-2 cell stage, and the second occurring during the morula-to-
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blastocyst transition [356].  While these transcriptional events are similar in the human embryo, 
the timing is different with the zygotic genome activation occurring at the 4-8 cell stage [357].  
Any irregularities during this critical time can lead to embryos that are incompetent and unable 
to implant.   
The interactions between the blastocyst and the uterus that result in successful implantation are 
directed by an equally complex molecular dialogue [358].  Uterine receptivity has been 
extensively studied on all molecular levels, including the cross-talk between the embryo and 
endometrium which is quite extensive and results in an environment ideal for embryo adhesion 
and placentation [359].  It has also been shown that viable mouse embryos have a specific gene 
expression profile that favors uterine attachment and invasion of the maternal endometrium.  
Chaen et al. found that ovarian estrogen indirectly coordinates mouse blastocyst adhesion 
through integrin activation in the blastocyst [360].  Additionally, a mammalian model for 
blastocyst activity has shown that specific molecular signaling directs either blastocyst activation 
or dormancy, affecting implantation competency [361].  Our lab has previously reported that 
differential mouse trophectoderm gene expression following embryo biopsy is associated with 
murine blastocyst implantation success [326].  Specifically, higher gene expression of B3gnt5, 
Cdx2, Eomes, and Wnt3a were predictive of sustained implantation.  In contrast, decreased gene 
expression of Eomes and Wnt3a were associated with absorption or pregnancy loss and 
decreased gene expression of B3gnt4 and Cdx2 were observed with negative outcomes [326].  
There is limited knowledge of the human pre-implantation embryo transcriptome and how it 
correlates to pregnancy outcomes. Jones et al. examined the transcriptome of human 
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trophectoderm biopsies and identified more than 7000 transcripts expressed exclusively in viable 
blastocysts [362].  A more recent study performed single-cell RNA sequencing on both human 
and mouse pre-implantation embryos to determine a dataset of genes that are important for 
pluripotency [363].  Ongoing transcriptome analysis in our lab revealed differential gene 
expression from blastocysts obtained from PCO women compared with donor controls. Over 800 
genes were found to be disrupted in these PCO blastocysts in addition to 12 altered protein 
biomarkers, demonstrating a link between patient infertility phenotype and embryo 
development [364].    
The objective of this study was to further explore the global transcriptome of human blastocysts 
from patients with differing infertility etiologies, specifically PCO, male factor, and unexplained 
infertility, to uncover novel biological pathways associated with their infertility that may 
influence downstream implantation outcomes.  These findings will further our understanding of 
the impact of infertility diagnoses on the embryonic molecular signature at the time of 
implantation, and may lead to refined lab-based and clinical approaches for improving IVF 
outcomes. 
11.4.4. Methods and Materials 
11.4.4.1. Human Blastocysts 
Surplus, cryopreserved, anonymous, human blastocysts from IVF patients with specific infertility 
diagnoses were donated with IRB. All embryos were considered to be transferable quality with a 
grade of 3BB or better on day 5 of embryo development [247]. Either slow freezing or vitrification 
protocols were used to cryopreserve the blastocysts [250, 365] which were grouped according 
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to a single distinct infertility diagnosis: n=50 young donor oocyte controls with no male factor 
infertility; n=50 polycystic ovaries (PCO); n=50 male factor infertility (MF); and n=50 unexplained 
infertility (UE). Every blastocyst used in this study came from a different patient (female <38 years 
old, male <40 years old) and all patients had successful pregnancies from the same IVF cohort as 
the blastocyst used for research.  Patients diagnosed with PCO had polycystic ovaries confirmed 
by ultrasound but did not have any endocrine or metabolic abnormalities, as determined by 
androgen levels, fasting glucose and insulin levels, and oral glucose tolerance testing. MF 
infertility patients were all diagnosed based on WHO guidelines as 
oligoasthenoteratozoospermia with sperm concentration <15 million/ml, motility <32%, and <4% 
normal morphology.  UE infertility was defined following a negative fertility workup which 
included normal semen analysis, normal ovarian reserve testing, and normal uterine assessment 
with no prior failures or missed abortions. 
11.4.4.2. Blastocyst Thaw and RNA Isolation 
Blastocysts were either thawed or warmed using routine laboratory procedures, with an overall 
95% survival rate. Blastocysts in each distinct infertility diagnosis group were pooled (n=25 per 
pool, two pools per group) and RNA was isolated using the PicoPure RNA Isolation Kit 
(ThermoFisher Scientific, Grand Island NY) per the manufacturer’s instructions with minor 
modifications.  Briefly, blastocysts were lysed in 10ul of Extraction Buffer before adding one 
volume of 70% ethanol and binding to a silica-based membrane.  Samples were then washed and 
on-column deoxyribonuclease treated (Qiagen, Valencia CA) prior to elution in 20ul and storage 
at -80°C. 
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11.4.4.3. Microarray Hybridization 
Isolated RNA from each group was reverse transcribed, amplified, and labeled using the LowInput 
QuickAmp Labeling Kit (Agilent Technologies, Santa Clara CA). Quantification and quality of total 
RNA was performed using the High Sensitivity RNA ScreenTape on a 4200 TapeStation System 
(Agilent Technologies).  Quantification and specific activity of labeled cRNA was determined using 
the NanoDrop® ND-1000 spectrophotometer (ThermoFisher Scientific).  600ng of cRNA was then 
applied to the SurePrint G3 Human Gene Expression Microarray containing 50,599 biological 
features (Agilent Technologies) per the manufacturer’s instructions and hybridized in a rotating 
oven for 17 hours at 65°C.  Arrays were washed and then scanned using a DNA Microarray 
Scanner C (Agilent Technologies).  Feature Extraction software was utilized to extract gene 
expression data (Agilent Technologies). 
11.4.4.4. Real-Time Quantitative PCR Validation 
RNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit 
(ThermoFisher Scientific).  cDNA was diluted 1:5 in nuclease-free water and Real-time 
quantitative PCR (RT-qPCR) was performed for validation of specific differentially expressed 
genes identified from the transcriptome analysis.  Absolute expression was quantified relative to 
a standard curve using slope and PCR efficiencies and normalized to a stable house-keeping gene, 
GAPDH.  Briefly, Power SYBR® Green PCR Master Mix (ThermoFisher Scientific) was combined 
with 5uM primer mix and 5ul diluted cDNA for a total volume of 25ul.  The reaction was incubated 
at 95°C for 10 minutes, followed by 40 cycles of amplification at 95°C for 15 seconds and 60°C for 
1 minute with a final dissociation stage for melt curve analysis. 
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11.4.4.5. Statistical Analysis 
Transcript analysis was performed using GeneSpring software (version 7, Agilent Technologies), 
including principal component analysis, unsupervised hierarchical clustering, one way ANOVA 
and unpaired t-test with Benjamini-Hochberg correction (significance at P<0.05).  qPCR analysis 
was performed with REST 2009 software (Qiagen) which uses the correction for exact PCR 
efficiencies with mean crossing point deviations between sample and control groups to 
determine an expression ratio that is tested for significance by a Pair Wise Fixed Reallocation 
Randomization Test.  Significance was defined as P<0.05. 
11.4.5. Results 
11.4.5.1. The Blastocyst Transcriptome According to Infertility Diagnosis 
The overall human blastocyst transcriptome contained 33,587 gene transcripts which included 
numerous splicing variants and isoforms, revealing 13,136 annotated genes.  PCA and 
unsupervised hierarchical clustering distinguished each of the four blastocyst groups by their 
transcriptomes (Figure 11.9). The most significant transcriptome variation was observed in 
blastocysts derived from infertile PCO patients. Compared to donor controls, significant 
differences in transcription (>2 fold; P<0.05) were observed for 869 genes in PCO blastocysts, 348 
genes in MF blastocysts, and 473 genes in blastocysts from couples with unexplained infertility 
(Figure 11.10).  Both up-regulation and down-regulation were observed in each group:  PCO = 
647 increased, 222 decreased; MF = 143 increased, 205 decreased; UE = 305 increased, 168 
decreased (Table 11.8). 




Figure 11.9: Differential transcriptome profiles based on infertility diagnosis. Human blastocyst 
transcriptomes from unexplained infertility (lanes one and two), polycystic ovaries (lanes three 
and four), male factor (lanes five and six), and control (lanes seven and eight). Unsupervised 
hierarchical clustering clearly separated the transcriptomes of the four groups, with the most 
significant variation in gene expression observed for the PCO group. 
Differential transcriptome profiles based on infertility diagnosis. Human blastocyst 
transcriptomes from unexplained infertility (UE) (lanes one and two, polycystic ovaries (PCO) 
(lanes three and four), male factor (MF) (lanes five and six) and control (lanes seven and eight). 
Unsupervised hierarchical clustering clearly separated the transcriptomes of the four groups, 
with the most significant variation in gene expression observed for the PCO group. 
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Figure 11.10: Venn diagram depicting gene overlap of differentially expressed transcripts 
between the infertility diagnoses groups. P < 0.05; >2-fold; one-way ANOVA and unpaired t-test 
with Benjamini–Hochberg correction. n = 1,385 genes. 
Functional annotation of PCO blastocysts was performed using DAVID (https://david.ncifcrf.gov) 
which revealed significant differences in gene ontology including:  cell communication, 
differentiation and adhesion, reproduction, transcription factor activity, regulation of apoptosis, 
receptor binding, signal transducer activity, and response to hormone stimulus.  Pathway analysis 
identified enriched biological processes with altered transcripts in PCO vs. control blastocysts 
(P<0.05) including gap junction proteins and genes involved in p53 signaling, calcium signaling, 
TGF-beta signaling, histidine metabolism, and apoptosis (Table 11.8).   
Transcriptome analysis of MF blastocysts resulted in some similar gene ontology differences in 
relation to PCO blastocysts that included:  signal transduction, regulation of apoptosis, cell 
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adhesion, reproduction and receptor binding.  Unique differences were also observed for MF 
including:  response to stress, regulation of growth, and protein dimerization activity.  Pathway 
analysis of MF vs. control blastocysts revealed enrichment in TGF-beta, ErbB, B cell receptor and 
GnRH signaling (Table 11.8).   
Functional annotation of UE blastocysts also had similar outcomes to PCO blastocysts in signal 
transducer activity, receptor binding, cell differentiation, adhesion and morphogenesis, 
reproduction, and response to stimulus, among others.  Unique differences for UE included:  
oxidoreductase activity, protein dimerization activity, and monooxygenase activity.  Pathway 
analysis of UE vs. control blastocysts had some similarities (TGF-beta signaling and focal 
adhesion) compared to the other two groups but many more differences including affected 
pathways:  Type I diabetes, antigen processing, leukocyte migration, autoimmune thyroid 
disease, systemic lupus erythematosus, mTOR signaling, and adipocytokine signaling (Table 11.8). 







# ↑ Genes 
(P<0.05; 
>2-fold) 
# ↓ Genes 
(P<0.05; 
>2-fold) 
Enriched Pathways                                              
(P<0.05; >2-fold) 
PCO 647 222 p53 signaling, TGF-beta signaling, 
apoptosis, histidine metabolism 
MF 143 205 TGF-beta signaling, ErbB signaling, GnRH 
signaling, B cell receptor signaling 
UE 305 168 mTOR signaling, autoimmune thyroid 
disease, systemic lupus erythematosus, 
Type I diabetes, and adipocytokine 
signaling 
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11.4.5.2. Microarray Validation 
RT- qPCR was used to validate the microarray data by investigating the expression levels of genes 
involved in stress response, apoptosis, cell growth and adhesion, and embryonic development.  
qPCR results confirmed a significantly higher expression of the stress sensing protein activating 
transcription factor 3 (ATF3) in PCO blastocysts compared to donor controls (P<0.05) and lower 
levels of anti-apoptotic oocyte-inherited gene (BCL2L10) (P<0.05) and the heat shock proteins 
HSPA1A and HSPA1B (P<0.05; Figure 11.11).  Blastocysts from patients with MF infertility 
displayed an increased expression of growth differentiating factor 15 (GDF15) (P<0.05) and the 
cell proliferation regulator, INHBA (P<0.05; Figure 11.12a) as observed in the microarray data.  
Additionally, reduced expression was validated in MF blastocysts for fibroblast growth factor 9 
(FGF9) (P<0.05), and left-right determination factors 1 and 2 (LEFTY1, LEFTY2) (P<0.05; Figure 
11.12b).  Three genes were also confirmed to have reduced expression in blastocysts with UE 
infertility as observed in the microarray data:  Adherens Junctions Associated Protein 1 (AJAP1), 
cadherin 9 (CDH9), and Laminin Subunit Alpha 4 (LAMA4) (All P<0.05; Figure 11.13). 
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Figure 11.11: Altered expression of genes involved in apoptosis and stress response in PCO 
blastocysts.  Quantitative PCR was performed to validate expression levels of ATF3, BCL2L10 and 
HSPA1A and HSPA1B in donor control and PCO blastocysts with PPIA transcription as the constant 
internal reference gene.  A significant increase in ATF3 expression was observed, while BCL2L10, 
HSPA1A and HSPA1B displayed significantly lower expression in PCO blastocysts, compared to 







































Figure 11.12: Altered expression of genes involved in cell growth and differentiation in MF 
blastocysts.  qPCR was performed to validate expression levels of GDF15, INHBA, FGF9, LEFTY1 
and LEFTY2 in donor control and MF blastocysts with GAPDH transcription as the constant 
internal reference gene.  (a) GDF15 and INHBA significantly higher in MF blastocysts compared 
to donor controls and (a)  Expression of FGF9, LEFTY1 and LEFTY2 were significantly lower; *P < 
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Figure 11.13: Altered expression of genes involved in cell adhesion and migration in UE 
blastocysts.  qPCR was performed to validate expression levels of AJAP1, CDH9 and LAMA4 in 
donor control and UE blastocysts with GAPDH transcription as the constant internal reference 
gene.  All three genes were significantly decreased in expression in UE blastocysts compared to 
donor controls; *P < 0.05; pairwise fixed reallocation randomization test. 
11.4.6. Discussion 
This study highlighted that the human blastocyst transcriptome is significantly impacted by the 
type of patient infertility diagnosis (PCO, MF, and UE).  All three of the infertility diagnoses shared 
transcriptome alterations, with PCO blastocysts displaying the greatest transcriptome variation.  
These results show that an altered blastocyst transcriptome has the potential to impact overall 
developmental competence, contributing to the infertility observed in patients with these 
etiologies. 
The expression of genes involved in stress response and apoptosis were significantly different in 
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impact on the developing blastocyst’s transcriptome, including alterations in stress signaling 
pathways and the regulation of apoptosis.  These findings are consistent with those of  Wang et 
al, who reported differential expression of 650 transcripts in the ovaries of women with PCOS 
compared to normal ovaries and found similar alterations in pathways involved in stress 
response, apoptosis, and regulation of transcription [366].  A higher expression of ATF3 and lower 
expression of BCL2L10, HSPA1A and HSPA1B in PCO blastocysts was observed in this study 
compared with donor controls.  ATF3, a stress sensor, increases p53 protein levels and 
transcription of p53-responsive genes that result in either cell arrest and DNA repair or apoptosis 
[367], thereby maintaining DNA integrity.  In the developing embryo, highly regulated apoptotic 
events are critical for embryo homeostasis and survival.  The BCL2 proteins are both anti- and 
pro-apoptotic; BCL2L10 is an anti-apoptotic oocyte-inherited transcript and elimination of 
BCL2L10 accelerates oocyte death [368].  HSPA1A and B are involved in embryonic genome 
activation and decreased expression has been observed in mammalian arrested embryos [369, 
370].  Likewise, gene expression analyses of oocytes from PCOS women also revealed reduced 
expression in these heat shock proteins [371].  Decreased fertilization rates after IVF, as well as 
a higher risk of miscarriage are associated with the PCO infertility diagnosis.  Altered expression 
levels of each of these genes in PCO may disrupt the normal balance of apoptosis in the pre-
implantation embryo, with downstream consequences for implantation and developmental 
outcomes. 
Blastocysts derived from MF infertility were significantly altered for TGF-beta and ErbB signaling 
pathways which are crucial during cell growth and proliferation.  GDF15 is a gene belonging to 
the TGF-beta superfamily and plays a role in regulating inflammatory and apoptotic pathways.  
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The increased expression observed for GDF15 in MF blastocysts is associated with numerous 
disease states including inflammation and oxidative stress.  Likewise, INHBA, which encodes the 
same TGF-beta superfamily of proteins, was also found to have increased expression in MF 
blastocysts.  It is a negative regulator of gonadal stromal cell proliferation, thus excess expression 
would lead to inappropriate decreases in cell proliferation which could negatively impact 
implantation potential.  Decreased gene expression in MF blastocysts was observed for FGF9, 
LEFTY1, and LEFTY2.  FGF9 is involved in many biological processes including embryo 
development, cell growth, and morphogenesis and has been found to be required for stimulating 
Erk1/2 activation in differentiating spermatogonia [372].  LEFTY proteins are critical in sustaining 
pluripotency and implicated in differentiation of embryonic stem cells [373].  Inactive LEFTY has 
been shown to result in embryos that become entirely mesoderm and fail to develop [374].  Poor 
sperm parameters in MF patients are correlated with fertilization failure and compromised 
embryo quality and development.  Decreases in the expression of these genes could severely 
impact embryo developmental competence, which is crucial for implantation. 
Important pathways including cell differentiation and morphogenesis, reproduction, and 
response to stress were affected from blastocysts derived from patients with UE infertility.  These 
pathways affect embryo growth and development as well as cell adhesion and migration.  
Decreased expression was observed for three genes involved in cell adhesion and migration:  
AJAP1, CDH9, and LAMA4.  AJAP1 has been observed to be decreased in various cancers and 
interacts with β-catenin complexes that impact cell cycle function and apoptosis [375].  The 
decreased expression observed in UE blastocysts could have a negative impact on the balance of 
apoptosis, possibly leading to inappropriate expression of genes that affect cellular invasion.  
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CDH9 belongs to a family of cell adhesion molecules that regulate morphogenesis and are 
involved in intracellular signaling pathways [376].  These cadherins are responsible for cell-cell 
adhesion during morula compaction, in addition to playing a role in tissue and organ 
development [377].  Decreased expression would inhibit the ability of both early embryo 
development, as well as later fetal development in utero.  LAMA4 is a laminin that mediates the 
attachment, migration, and organization of cells into organized tissues during embryonic 
development.  Laminins are vital for organogenesis and have critical functions in several tissues 
including skin, muscle, and vasculature [378].  As the etiology of UE infertility is more ambiguous, 
many adverse outcomes are possible including poor embryo development and IVF failure.  The 
decreased expression observed in UE blastocysts could have significant consequences to embryo 
implantation and ongoing development. 
The similarities between all infertility groups included transcriptome alterations in signal 
transducer activity, receptor binding, reproduction, cell adhesion, and response to stimulus.  
These biological and molecular processes are all inter-related and crucial to embryo development 
and implantation which are processes characterized by cells that proliferate, migrate, and attach.  
Receptors are generally transmembrane protein molecules that bind to signaling molecules in 
response to external stimuli.   Once a receptor protein receives a signal, a series of biochemical 
reactions are initiated which convey those signals across a cell, triggering changes in cell function 
or state, known as signal transduction.  An example of this is Hedgehog (Hh) proteins which are 
expressed during vertebrate development.  Hh signaling has been observed during embryonic 
development and has significance during the growth of reproductive tissues including the gonad 
and uterus [379].  Cellular adhesion, in which cells interact to attach to a surface, regulates signal 
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transduction and is an essential process for embryo implantation into the uterus lining.  It is 
therefore not surprising that all three infertility diagnoses shared blastocysts with transcriptome 
alterations in these important biological and molecular processes. 
The differences between each infertility group were more remarkable when studying their 
pathway analyses.  Blastocysts from women with PCO were enriched for apoptosis.  This is in 
concordance with data published showing that ovaries from women with PCO have abnormal 
apoptotic activity and folliculogenesis [380].  On the other hand, signaling pathways from 
blastocysts with MF infertility were largely involved in cancer processes.  Lian et al. also found 
that infertile men with maturation arrest had hyperactive germ cell proliferation as a result of 
the inhibition of tumor suppressor IRF1 by its microRNA, miR-383 [381].  Interestingly, UE 
infertility was enriched for pathways involved in mTOR and adipocytokine signaling, both of 
which are related to various disease states.  This could explain some of the difficulties in treating 
patients with unknown infertility as the cause of their reproductive deficiencies could be the 
result of anything ranging from environmental to unknown disease risk factors.  For example, 
autoimmune disorders, such as lupus, have been shown to cause a woman’s immune system to 
reject an embryo, thereby preventing implantation into the uterus [382]. 
This novel study suggests that underlying patient infertility diagnosis has an impact on the 
blastocyst transcriptome, modifying genes that may affect developmental competence and 
implantation outcomes. Ongoing research determining how transcription alterations are linked 
to inferior pregnancy outcomes for PCO, MF, and UE patients is crucial to improving IVF success.  
This is especially true for UE patients as a more defined infertility diagnosis could translate into 
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more targeted clinical management.  Understanding how different infertility etiologies 
contribute to embryo viability may also lead to the development of new laboratory and clinical 
therapies.  An example of this type of clinical advancement is the endometrial receptivity array 
which identifies endometrial receptivity for patients with repeated implantation failure [383].  
Further studies could lead to similar advancements including individualized embryo culture 
systems and custom stimulation and frozen embryo transfer protocols, thereby improving 
outcomes for these patients. 
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11.5. Specific Aim 5 
To explore the presence of pathogenic variants in patients with premature diminished ovarian 
reserve and any downstream molecular impact on the developing embryo. 
The following submitted work is presented for this specific aim: 
BR McCallie, ME Haywood, MM Denomme, R Makloski, JC Parks, DK Griffin, WB Schoolcraft, 
MG Katz-Jaffe.  Submitted Sept 2020. 
11.5.1. My Personal Contribution to the Work 
For this study I isolated all RNA and DNA and performed quantity and quality checks.  I also 
performed all genotyping reactions for validation and subsequent analyses.  Additionally, I wrote 
and edited the manuscript. 
11.5.2. Chapter Summary 
The objective of this study was to investigate the biological networks associated with premature 
diminished ovarian reserve in young women and the subsequent molecular impact on pre-
implantation embryos.  Whole peripheral blood was collected from female subjects with patient 
consent and IRB approval: young women presenting with diminished ovarian reserve (DOR) and 
age-matched young women with normal ovarian reserve (CONT).  A diagnosis of young DOR was 
defined as maternal age ≤34 years (range 27-34), antral follicle count <10 and/or AMH <1.0 
(ng/ml).  Maternal exome sequencing identified exclusive DOR variants using Ingenuity Pathway 
Analysis.  Sequencing validation was performed with Taqman® SNP Genotyping Assays. 
Blastocyst global methylome and transcriptome sequencing were performed with subsequent 
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statistical analyses set at a significance of P<0.05.  Exome sequencing revealed 730 significant 
DNA variants across the genome that were observed exclusively in the young DOR patients 
(P<0.01).  Bioinformatic analysis revealed a significant impact to the Glucocorticoid receptor (GR) 
signaling pathway (P<0.01).  Each young DOR female had an average of 6.2 deleterious DNA 
variants within the GR signaling pathway. Successful validation included gene members of the GR 
signaling pathway (AGT, KRT6A, KRT19, NCOA2, TAF1) and key ovarian genes (AHRR, CCDC8, 
IGFBP5, LRRC17, PCDH11X, PDGFD).  Additional stratification based on patient age resulted in a 
cut-off at 31 years for young DOR discrimination.  Embryonic global methylome sequencing 
resulted in only a very small number of total CpG sites with methylation alterations (1,775; 
0.015% of total) in the DOR group (P≤0.05).  Additionally, there was no co-localization between 
these limited number of altered CpG sites and significant variants, genes or pathways.  RNA 
sequencing also resulted in no biologically significant transcription changes between DOR 
blastocysts and controls (P≤0.05). 
11.5.3. Introduction 
Ovarian reserve plays a crucial role in determining female reproductive potential and as women 
age their ovarian reserve naturally declines.  Diminished ovarian reserve is a condition 
characterized by a decline in the quantity and/or quality of oocytes remaining in the ovaries and 
has been associated with infertility including reduced pregnancy success, and poor response to 
ovarian stimulation during infertility treatment [15, 16].  DOR is common as women reach 
menopause but about 10% of all women are at risk of being impacted by premature DOR earlier 
in their reproductive lifespan [19].  The causes of this early onset DOR remain largely unknown.  
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Although some studies have found evidence of pathogenic mutations in genes like FMR1, GDF9, 
and SF1, the vast majority (90%) of cases have no specific cause identified [384-387].   
Measurement of ovarian reserve is determined by an ovarian ultrasound alongside serum 
reproductive hormone levels including AMH, day-3 follicle-stimulating hormone (D3 FSH), and 
Estradiol.  While FSH alone has poor predictive value and high intercycle variability, the sensitivity 
can be enhanced when combined with Estradiol.  AMH, on the other hand, is cycle independent 
and can more accurately predict ovarian reserve and response to ovarian stimulation [388].  DOR 
is typically diagnosed by a combination of these variables, although there is no universal criteria.   
There is currently no treatment to prevent or slow down the ovarian aging process.  Once a 
woman is diagnosed with DOR, even in the earliest stages, the chances for successful pregnancy 
outcomes are lower than in age-matched women with normal ovarian reserve [389].  Assisted 
reproductive technologies offer treatment options but even then, due to the significantly 
diminished number of oocyte producing follicles, this remains a difficult population to treat.   
Previous publications have linked genetic variants including single-nucleotide polymorphisms to 
diminished ovarian reserve and ovarian failure [390-393].  These studies have largely targeted a 
small number of genes involved in follicular function (GDF9, BMP15, and AMH) in an effort to 
understand the causes associated with ovarian disease or to assist in molecular diagnosis of 
female infertility.  A recent study looked at FMR1 in the blood from DOR patients who had the 
FMR1 gene premutation.  They found epigenetic marks in the regulatory regions that resulted in 
increased gene expression [192].  Another study found fewer FMR1 CGG repeats in women with 
DOR compared to those with a normal reproductive history [394].  Most recently, Tang et al. 
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conducted whole exome sequencing on blood from women with POI and DOR and found 79 
heterozygous variants that overlap between the two diagnoses and the decline in ovarian 
function is likely polygenic [395].  Despite these efforts however, little is known with regards to 
genetic risk or predisposition for premature DOR and there are no diagnostic indicators to aid in 
early diagnosis that would allow for intervention or the option of preservation for future fertility.   
Therefore, the objective of this study was to investigate the genomic landscape of young women 
presenting with premature DOR in an effort to understand the biological mechanisms associated 
with the disease, the downstream impact on embryonic transcription, and to ascertain if there is 
any clinical utility in analyzing SNPs as a potential diagnostic in association with predisposition 
for DOR.   
11.5.4. Methods and Materials 
11.5.4.1. Maternal Exome Sequencing 
Whole peripheral blood was collected from IRB consented female patients at a single infertility 
clinic and donated to research:  young women with normal ovarian reserve presenting with a 
variety of male and female indications for infertility treatment (CONT ≤ 34 years; n=11; mean AFC 
= 22.1, mean AMH = 3.5 ng/ml) and age-matched young women presenting with diminished 
ovarian reserve (DOR ≤ 34 years; n=11; mean AFC = 9.1, mean AMH = 0.59 ng/ml).  A diagnosis 
of DOR was defined as an antral follicle count of < 10 and/or an AMH of < 1 ng/ml.  Blood was 
collected on the same day measurements were taken and frozen prior to storage at -80°C until it 
was further processed.  Once all samples had been collected, blood was thawed and equilibrated 
to room temperature prior to isolating DNA using the QIAamp DNA Blood Mini kit (Qiagen) 
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following manufacturer’s instructions.  Purified DNA was eluted in 200ul Buffer AE and tested for 
quantity and quality using the NanoDrop One (Thermo Scientific).  Variants were identified by 
whole exome sequencing where 200ng of purified DNA were utilized for exome enrichment 
(n=22; SureSelectXT, Agilent) and sequenced on the NovaSEQ 6000 (Illumina).   
11.5.4.2. Maternal Genotyping Validation 
DNA was isolated from additional stored blood samples for sequencing validation in the same 
manner as previously described (n=58).  Purified DNA was used for genotyping reactions on a 
real-time PCR platform (7300 Real Time PCR System, Applied Biosystems).  Briefly, Predesigned 
Taqman™ SNP Genotyping Assays were combined with Taqman™ Genotyping Master Mix (1X 
final concentration) and 10ng of DNA prior to amplification using the following thermal cycling 
conditions:  95°C for 10 minutes and 40 cycles at 95°C for 15 seconds and 60°C for 1 minute.  A 
pre-PCR plate read was performed to record the background fluorescence of each well before 
amplification.  After amplification, the pre-PCR plate read was subtracted from the post-PCR 
plate read to account for pre-amplification background fluorescence.  Taqman® Genotyper 
Software was used to analyze the data and make allele calls.  Allelic discrimination scatter plots 
were generated to distinguish homozygous for allele 1, homozygous for allele 2, or heterozygous 
for each SNP tested. 
11.5.4.3. Embryonic Methylome and Transcriptome Sequencing 
Embryonic trophectoderm methylome sequencing from individual blastocysts (n=6) was 
performed using the Methyl Maxi-Seq platform (Zymo Research) as previously described [396].  
Briefly, extremely-low-input library preparation (Pico Methyl-Seq Library Prep Kit; Zymo 
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Research) was followed by adapter sequence addition, PCR purification (DNA Clean & 
Concentrator 5; Zymo Research), and sequencing on the Illumina HiSeq 2500 platform.   
Transcriptome sequencing of individual blastocysts (n=12) was performed as previously 
described [396].  RNA isolation (Picopure RNA Isolation Kit; Thermo Fisher) and library 
preparation (Low Input Library Prep Kit; Clontech) were followed by small-cell number RNA-Seq 
(Illumina HiSeq 4000).   
11.5.4.4. Omics and Bioinformatic Analysis 
11.5.4.4.1. Exome 
Reads were processed according to Genome Analysis Toolkit (GATK) best practice 
recommendations using the GATK4 exome analysis pipeline (v1.0.0) available on GitHub 
(https://github.com/gatk-workflows/gatk4-exome-analysis-pipeline).  Briefly, reads were aligned 
to the hg38 reference genome using BWA-MEM (v0.7.17).  Duplicate marking, base quality 
recalibration, and variant calling in GVCF mode were performed using the toolkit v4.1.0 (Broad 
Institute, Cambridge, MA).  All GVCFs were merged for joint genotyping and variant quality score 
recalibration.  Recalibration for SNPs was performed using Hapmap 3.3 as a truth and training set 
with 1000 genomes OmniExpress 2.5 and 1000 genomes Phase1 SNPs as training sets.  
Recalibration for indels was performed using the Mills and 1000 genomes gold standard dataset 
as a truth and training set.  All recalibration used dbSNP 138 as known variants.  Variants were 
annotated using the Ensembl Variant Effect Predictor (v95.3).  To be considered for further 
analysis, variants had to be present in at least two or more DOR patients or have two or more 
different variants in two or more DOR patients within the same gene.  SIFT, PolyPhen (probably 
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or possible deleterious), and MutationTaster (D) algorithms were used to predict deleteriousness 
of variants.  A SIFT rating of “deleterious”, a PolyPhen rating of “possibly” or “probably 
deleterious”, and a MutationTaster rating of “D” were considered deleterious.  Variant frequency 
information was obtained from the Genome Aggregation Database [397].  Genes were 
interpreted using Ingenuity Pathway Analysis (IPA; Qiagen, Redwood City, CA) and genes specific 
to ovarian function were determined using The Human Protein Atlas 
(https://www.proteinatlas.org/humanproteome/tissue/ovary).  A dataset of Ensembl gene 
identifiers was uploaded for Core Analysis.  Results with P-value ≤ 0.05 were considered 
significant. 
11.5.4.4.2. Methylome 
Sequence reads were identified using standard Illumina base-calling software, and Bismark 
software was used for bisulfite sequence data alignments.  Index files were constructed using the 
human genome (hg19).  Student T-Test was used to quantify the statistical significance of the 
methylation difference between DOR and control (donor egg) groups, where P ≤ 0.05 was 
considered significant. 
11.5.4.4.3. Transcriptome 
Reads were mapped to the human genome (hg19) using gSNAP, and gene expression values 
(expressed as fragments per kilobase per million [FPKM]) were derived by Cufflinks. ANOVA in R 
was used to quantify the statistical significance of the differential expression, where P ≤ 0.05 and 
Q ≤ 0.05 were deemed to be significant.  
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11.5.5. Results 
11.5.5.1. Maternal Exome 
Maternal exome sequencing resulted in a total of 864,768 SNPs identified across all samples.  
Bioinformatic analysis filtered for only SNPs identified in protein-coding regions, present in more 
than half the samples, and absent in controls resulting in 103,460 SNPs.  Further advanced 
filtering for rare, predicted pathogenic, and protein-altering (indel/splice/gained/lost/missense) 
SNPs identified 730 differentially significant variants between DOR and controls (Supplementary 
Table 2; P < 0.05).  Pathway analysis on these 730 significant pathogenic variants revealed the 
Glucocorticoid Receptor (GR) signaling pathway to be the most highly enriched (P < 0.01), 
specifically the Glucocorticoid Response Elements (GRE) portion of the pathway (Figure 11.14).  
Each young DOR patient had an average of 24.3 total SNPs and 6.2 predicted pathogenic DNA 
variants impacting the GRE (Table 11.9; P = 0.002).  Additional bioinformatic analysis of SNPs 
completely absent in controls and present in three or more DOR patients resulted in 1,196 SNPs.  
Of these, there were six protein-altering variants in genes with elevated ovarian protein 
expression (AHRR, CCDC8, IGFBP5, LRRC17, PCDH11X, and PDGFD).  These genes, along with 
several members of the GR signaling pathway (AGT, KRT6A, KRT19, NCOA2, and TAF1) were 
chosen for validation.   Validation on additional DOR and control samples using genotyping 
analysis was successful for all 11 pathogenic variants identifying the same allele change observed 
in the exome sequencing data. 
Biological Mechanisms Impacting Pre-Implantation Embryo Development 
140 
 
Figure 11.14: GR signaling pathway.  Red indicates genes of interest with DNA variants observed 
in young DOR patients.  In the absence of glucocorticoids, the glucocorticoid receptor (GR) resides 
inactive in the cytoplasm in a chaperone protein complex (HSP-90, Dynein, FKBP52). When 
glucocorticoids passively diffuse into cells, they bind with the GR to induce conformational 
changes and subsequent dissociation from HSP-90. The GR translocates to the nucleus and binds 
to negative and positive response elements to modulate gene expression resulting in the 
activation or repression of genes. In some cases, the GR effects on gene expression occur in 
combination with other transcriptional regulators. Overall, the actions of the GR can result in a 
variety of effects including T-lymphocyte apoptosis, anti-inflammatory response, neutrophil 
infiltration, cardioprotection, and cell proliferation. 
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Table 11.9: Total variants vs. protein-altering variants per patient in the GR signaling pathway. 
Table 9A: The total number of variants per patient in the GR signaling pathway (P=0.09, ns) 
DOR1 DOR2 DOR3 DOR4 DOR5 DOR6 DOR7 DOR8 DOR9 DOR10 DOR11 Total Avg 
21 18 17 30 34 22 24 28 29 21 23 267 24.3 
 
CONT1 CONT2 CONT3 CONT4 CONT5 CONT6 CONT7 CONT8 CONT9 CONT10 CONT11 Total Avg 
13 15 17 26 24 34 24 7 19 16 18 213 19.4 
 
Table 9B: Protein-altering variants per patient in the GR signaling pathway (*P=0.002) 
DOR1 DOR2 DOR3 DOR4 DOR5 DOR6 DOR7 DOR8 DOR9 DOR10 DOR11 Total Avg 
4 7 4 3 9 8 5 8 4 6 10 68 6.2* 
 
CONT1 CONT2 CONT3 CONT4 CONT5 CONT6 CONT7 CONT8 CONT9 CONT10 CONT11 Total Avg 
4 4 0 6 3 3 3 1 3 3 3 33 3.0 
Stratification of validated data based on patient age was performed which resulted in a cut-off 
at the age of 31 that clearly distinguished DOR women from control.  DOR women in this study 
between the ages of 27-31 had at least one pathogenic variant present (anywhere from 1-6 
variants with an average of 2.9 per patient; P < 0.05) while age-matched control patients had no 
pathogenic variants observed for any of these 11 targeted SNPs (Table 11.10).  However, as the 
control group aged, protein-altering variants were detected and were in fact evident in the 
majority of control patients by the age of 34.  It is important to note that while these women are 
still considered reproductively young and had normal ovarian reserve, they were still an infertile 
population, seeking ART to conceive.  
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Table 11.10:  Genotyping variants present in both DOR and CONT patients, stratified by age.  X indicates a heterozygous alteration and 
XX represents a homozygous allele change.  No changes are observed in young DOR patients <32 years of age. 
 
Age 27 29 29 29 29 29 30 30 30 31 31 32 32 32 32 32 32 33 33 33 33 33 34 34 34 34 34 34 34
DOR12 DOR13 DOR14 DOR15 DOR16 DOR17 DOR18 DOR19 DOR20 DOR21 DOR22 DOR23 DOR24 DOR25 DOR26 DOR27 DOR34 DOR28 DOR29 DOR30 DOR31 DOR32 DOR40 DOR41 DOR42 DOR43 DOR44 DOR45 DOR46
PCDH11X X X X X
CCDC8-1 X X X X
CCDC8-2 X X X X
PDGFD X XX X X
LRRC17 X X X X X X X X
IGFBP5 X X X X
AHRR-1 X X XX X X XX X X X X X X
AHRR-2 X X XX X X XX X X X X X X
Vairants present? P P P P P P P P P P P P P P P P P P P P P
Total # of variants 1 2 3 1 3 2 5 1 4 6 4 0 3 0 0 1 0 0 2 1 1 2 0 2 0 2 2 0 2
CONT12 CONT13 CONT14 CONT15 CONT16 CONT17 CONT19 CONT20 CONT21 CONT22 CONT23 CONT24 CONT25 CONT26 CONT27 CONT28 CONT29 CONT30 CONT31 CONT32 CONT33 CONT34 CONT40 CONT41 CONT42 CONT43 CONT44 CONT45 CONT46
PCDH11X X
CCDC8-1 X XX X X




AHRR-1 XX XX X X X
AHRR-2 XX XX X X X
Vairants present? P P P P P P P P P
Total # of variants 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 2 0 0 0 1 0 1 2 5 2 2 3
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11.5.5.2. Trophectoderm Methylome 
The bisulfite conversion rate was >95% for whole genome bisulfite sequencing of embryonic 
samples, and averages for the samples included >772 million read pairs, >12 million unique CpGs, 
with 41X average CpG coverage.  Across the blastocyst trophectoderm epigenome, only a very 
small number of CpG sites had altered methylation (1,775; 0.015% of total reads) indicating that 
the DNA methylation landscape is generally preserved.   1,138 CpG sites were significantly 
hypermethylated, and 637 CpG sites significantly hypomethylated in the DOR group compared 
with controls (P < 0.05).  Less than half (48.4%) of these differentially methylated CpGs 
corresponded to known gene regions with an average of only 1.1 significant CpGs per gene and 
only 6% were localized to promoter sites that have the potential to impact expression. 
Genes identified by exome sequencing in DOR blood samples did not co-localize with any of the 
differentially methylated CpG sites in blastocysts; neither directly overlapping, nor within the 
same genes, or even cytobands of the genome.  Only small changes were observed, indicating 
that the DNA methylation landscape is generally preserved. 
11.5.5.3. Blastocyst Transcriptome 
The filtered reads distribution averaged 58 million single-end reads for small cell number RNA-
seq on individual blastocysts, with an average of 2,754 mb, yield quality of >95% Q30 bases, and 
a mean quality score of 39.  A strict expression cutoff of 5 FPKM was used to remove false 
positives at or near baseline expression levels.  Transcriptome data analysis resulted in only six 
significantly altered transcripts (P ≤ 0.05, Q ≤ 0.05) between the DOR blastocysts and controls out 
of 66,095 gene annotations total.  Of these, four displayed decreased gene expression levels in 
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blastocysts from DOR women (MED28, SLCO2B1, DOCK5, RP11-400N13.2) and two had increased 
expression (RP11-522I20.3, P2RX5-TAX1BP3).  There was no biological relationship between this 
very small number of transcriptionally altered genes and genes with differentially methylated 
CpGs in the blastocyst, nor in association with genes identified by exome sequencing in maternal 
DOR blood. 
11.5.6. Discussion 
This study observed pathogenic variants in the DNA sequence of key genes associated with 
ovarian function among young women presenting with premature diminished ovarian reserve.  
This data could explain the compromised oocyte production and quality typical of this patient 
population and potentially provide the ability to predict premature DOR.  Earlier identification 
would allow for clinical intervention prior to functional ovarian decline. 
The GR signaling pathway was found to be significantly altered in young DOR patients compared 
to age-matched controls.  Glucocorticoids (GCs) are steroid hormones that, among other actions, 
control inflammation [398].  GCs are mediated by the activation of GRs which control a number 
of biological functions including reproduction and development [399].  One way the GR pathway 
regulates gene expression is through GRE binding resulting in chromatin remodeling and 
activation of transcription [398].  Several genes of interest in the GR pathway displayed SNP 
alterations in the maternal exome from DOR patients (AGT, KRT6A, KRT19, NCOA2, and TAF1).  
Targeted disruption of AGT has been shown to decrease fertility and significantly reduce oocyte 
production in mice [400].  Polymorphisms to AGT could therefore partially explain the diminished 
ovarian function observed in women with DOR.  Likewise, keratins are involved in epithelial cell 
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integrity and play an important role in epithelial cell protection [401].  Ovarian surface epithelium 
is vital for regeneration and cell proliferation post ovulation [402].  The variants observed in both 
KRT6A and KRT19 might very well affect the ability of the ovary to regenerate, thereby 
diminishing oocyte reserve.  NCOA2 aids in the function of nuclear hormone receptors which are 
critical in cell growth and development.  These receptors are also required for follicular 
development and include FSH and LH [403].  The reduction of these hormones observed in 
women with DOR could be a result of alterations to NCOA2 inhibiting hormone production.  
Finally, TATA-box binding protein associated factors (TAFs) function as master regulators of 
differentiation and proliferation and have been implicated with ovarian tumor progression [404].  
TAF1 is the largest subunit of TFIID complex which is a key contributing factor in human oogenesis 
and could be a potential biomarker for oocyte quality [405].  The compromised oocyte reserve 
and quality observed in women with DOR could be impacted by the polymorphisms observed in 
the TAF1 gene. 
Likewise, several genes with elevated ovarian expression were also observed to have variants in 
this study (AHRR, CCDC8, IGFBP5, LRRC17, PCDH11X, and PDGFD).  These genes were identified 
as being highly expressed in the ovary relative to other tissues and are associated with follicle 
growth, oocyte maturation, ovarian cancers, and genome instability, among others [406-413].  
These variants were of particular interest because they were only detected in the exome from 
DOR patients and older women in the control group (>31 years of age).  No polymorphisms for 
any of these genes were evident in any women younger than 32 years of age with normal ovarian 
reserve.  This not only highlights the fact that, as women age, these important ovarian genes are 
being altered but also that these could be potential biomarkers for early onset diminished ovarian 
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reserve.  AHR is a ligand-activated nuclear transcription factor and its gene expression has been 
widely studied [414].  It plays a vital role in the ovary by inducing natural apoptosis in oocytes 
and regulating follicle growth in the later stages of folliculogenesis [414].  AHR also likely plays a 
role in regulating steroid hormone production in the ovary including LH, FSH, and estrogen [414].  
CCDC8 functions as a cofactor for p-53-mediated apoptosis following DNA damage and is 
involved with syndromes associated with altered FSH levels [415].  IGFBP5 plays a role in cell 
growth, differentiation, and apoptosis and has been found to be highly downregulated in ovarian 
cancer tissue [416].  LRRC17 plays an important role in cell viability by protecting against p53-
dependent apoptosis and has been associated with ovarian cancer [417].  CNVs in PCDH11X have 
been associated with primary ovarian insufficiency [418].  Lastly, PDGFD is regulated by LH and 
has been found to be decreased in the follicular fluid of women with PCOS [419].  It is likely that 
variants in these genes are resulting in hormone insufficiencies and DNA damage in the ovaries 
of patients presenting with DOR.  However, it is imperative to note that the control group in this 
study consisted of women who presented with no known infertility diagnoses but are still 
considered an at-risk population as they were seeking ART to conceive.  The increase in the 
presence of SNP alterations observed in this group, beginning at the age of 32, is likely due to 
natural aging for a sub-fertile or infertile population. 
Finally, this study analyzed both the embryonic methylome and transcriptome created from 
women with premature DOR.  We did not observe any co-localization among genes harboring 
embryonic epigenetic alterations and the maternal SNP variants in the exome from women with 
DOR.  Additionally, only a small percentage of the identified alterations were situated in gene 
promoter regions, suggesting a very limited number of these differentially methylated CpGs even 
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had the potential for functional consequences.  This was certainly observed in this study as only 
trivial changes to embryonic gene expression were observed.  These combined results indicate 
that despite premature DOR and decreased oocyte production, embryos derived from these 
patients have good potential for reproductive success.  Indeed, while this patient population has 
severe defects to ovarian function and oocyte reserve, the oocytes themselves appear to be 
competent.  This signifies that the germline is not being impacted due to ovarian cells aging 
prematurely.  Other studies have also confirmed this observation.  Chang et al. found that while 
young women with DOR indeed have limited ovarian response and low numbers of mature 
oocytes in an IVF cycle, the chances of obtaining a high-quality embryo and clinical pregnancy 
were much higher than their older counterparts [420].  Likewise, another recent study found that 
diminished ovarian reserve is not associated with a higher risk of miscarriage in younger women 
who utilize ART to conceive [421]. 
In conclusion, despite the premature decline of ovarian production in the DOR patient 
population, no significant downstream effects on biological processes appear to impact the 
resulting blastocyst.  Rather, the importance of diagnosing early onset DOR is emphasized, 
enabling the retrieval of oocytes that have the ability to produce transferrable quality blastocysts.  
This study highlights the potential for utilizing SNPs as a prognostic tool for predicting early onset 
diminished ovarian reserve before a woman could otherwise be diagnosed by traditional means, 
thereby allowing intervention and the greatest possibility of fertility preservation. 
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12.0 General Discussion 
This thesis was largely successful in the fulfillment of the stated aims: 
1. To test the hypothesis that embryonic miRNAs are impacted by advanced maternal age 
and/or chromosome constitution. 
2. To test the hypothesis that the embryonic transcriptome is impacted by advanced 
maternal age. 
3. To test the hypothesis that methylation alterations explain differing implantation 
potential among aneuploid blastocysts in correlation with chromosome constitution. 
4. To establish whether underlying infertility diagnoses (polycystic ovaries, male factor, and 
unexplained) have an impact on the transcriptome of developing blastocysts. 
5. To explore the presence of pathogenic variants in patients with premature diminished 
ovarian reserve and any downstream molecular impact on the developing embryo. 
Both maternal age and chromosome constitution impact RNA regulation during early embryo 
development.  These alterations significantly impact biological pathways associated with cell 
growth and invasion which are vital to implantation. 
Likewise, maternal age has an impact on the overall transcriptome of the developing embryo.  A 
global decrease in expression is observed in blastocysts from older women that have a particular 
effect on upstream regulators involved in cell growth and invasion, which are crucial to 
development and implantation. 
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Methylation alterations are present in monosomic blastocysts which may contribute to reduced 
implantation potential.  A hypomethylated state is identified in monosomic embryos but only in 
the chromosome involved in the error.  Likewise, decreased expression of developmental genes 
located on the chromosome of error are also observed.  In contrast, trisomic blastocysts display 
transcriptional dosage compensation mechanisms that might partially explain the difference in 
implantation potential between trisomic and monosomic embryos. 
Infertility diagnoses have a significant impact on the transcriptome of the early embryo.  All three 
diagnoses examined (PCO, male factor, and unexplained) have alterations to various pathways 
that are essential for cell proliferation, migration, and attachment which are necessary for 
embryo development and implantation. 
Young patients with premature diminished ovarian reserve are shown to have pathogenic 
variants that could represent an early point of diagnosis.  Additionally, despite the reduced 
numbers of oocyte producing follicles in this patient population, there does not appear to be 
significant embryonic molecular changes. 
One of the greatest aims during an IVF cycle is to select the most competent embryo that will 
achieve a live birth in the shortest amount of time.  SART data from 2018 analyzing only euploid, 
day 5/6 embryos used for transfer shows an implantation rate of ~50-63% depending on the age 
of the mother.  This number improves only slightly when filtering for gestational carriers, 
suggesting that blastocyst implantation in an IVF setting is largely dependent on the embryo 
itself.  With nearly half of all normal embryos in the clinic failing to implant, we still have very 
limited knowledge of the biological mechanisms behind why these morphologically good-quality 
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embryos have poor implantation potential.  There is a need to have the ability to examine an 
embryo’s developmental competence on a molecular level to improve IVF outcomes. 
Embryo-endometrium crosstalk is an important process during the window of implantation.  
Many studies have investigated this molecular dialogue and a receptive uterus is required for 
successful implantation to occur [422].  However, we also understand that older women who fail 
to conceive while utilizing ART and their own eggs, can achieve good pregnancy outcomes when 
using donor oocytes from younger women.  In addition, it has been suggested that the embryo 
can signal the endometrium to actively promote or prevent implantation, conveying its own 
developmental potential [423].  Therefore, while the endometrium plays an important role 
during the process of implantation, the competency of the embryo itself is vital.   
The overall aim of this thesis was to better understand these biological mechanisms responsible 
for embryonic competence that could result in reproductive success.  In each study, cell growth, 
proliferation, and migration were found to be compromised.  This is not surprising for 
embryogenesis as it is well understood that the early embryo must migrate to the implantation 
site of the endometrium, attach to the endometrial epithelium, and invade the endometrial 
stroma [424].  Likewise, these factors were found to be significant when considering 
folliculogenesis and oocyte maturation.  A quality oocyte is the foundation for producing a 
competent embryo that will have good implantation potential.  It is therefore not surprising that 
these biological mechanisms were found to be significantly impacted in relation to both 
oogenesis and embryogenesis.   
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Another common theme among all five studies was the concept of the interplay between 
oxidative stress, DNA repair, apoptosis, and/or inflammation.  Oxidative stress is marked by a 
state of imbalance between pro- and anti-oxidant molecules, which can include increased ROS 
levels or decreased antioxidant defense mechanisms [254, 425, 426].  In the ovary, this 
relationship is complex.  For instance, increased ROS allows the resumption of meiosis I in the 
dominant oocyte, however, meiosis II is promoted by antioxidants [427].  Additionally, ovulation 
commences with the LH surge and inflammatory precursors that generate ROS, but any depletion 
of these precursors will impair ovulation [428].  Oxidative stress can also harm the developing 
embryo through mitochondrial alterations, ATP depletion, and apoptosis among others [429].  
However, ROS are generated during normal embryo metabolism.  The embryo is reliant on 
protection by antioxidant enzymes that must be properly stored in the oocyte during the later 
stages of maturation [429].  We know that increased oxidative damage is observed in relation to 
various infertility diagnoses including all diagnoses examined within this thesis [254] which is 
likely causing damage to ovulation and/or embryo development, limiting the implantation 
potential of embryos in these patient cohorts. 
The research presented in this thesis found an overall compromised molecular landscape 
impacting cell growth, proliferation, and migration, in addition to apoptosis and inflammation 
which are all vital to appropriate embryonic cell development and attachment.  A greater 
understanding of the molecular and biological mechanisms associated with embryo implantation 
has the ability to improve clinical management and pregnancy success.  The DOR study analyzing 
SNP variants has the most promise in being utilized as a diagnostic assay.  Future studies will 
include additional analysis of varying age groups, as well as different severities of disease.  It is 
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important to understand how these variants alter with fluctuating DOR etiologies.  The potential 
for a simple blood draw, followed by SNP analysis, would provide patients with prognostics on 
oocyte health in as little as 24 hours which could greatly benefit their future fertility.   
Since the publication of the articles found within this thesis, many advances have been made in 
the biological field of infertility studies.  For instance, miRNAs have become common areas of 
interest for various types of research.  These small RNAs have been extensively studied in 
embryos, ovaries, culture media, and follicular fluid among others [430-433].  Additionally, 
transcriptomic studies have become commonplace and the technology has advanced from 
utilizing RT-qPCR and microarray to next generation sequencing platforms.  Many transcriptomic 
studies have since been performed on pre-implantation embryos which continues to increase 
our knowledge of the biological mechanisms that take place during embryo development and 
implantation.  For instance, when comparing human embryonic genetic profiling using 
microarray compared to RNA-seq, the number of maternally expressed genes discovered 
increased from 9,735 to 22,687 including 8,701 lncRNAs that had never been analyzed [434].  
Next generation sequencing has also made it possible to determine biomarkers for a variety of 
fertility-related questions including male infertility and endometrial receptivity [435, 436].  
Continuing to explore these biological mechanisms through advances in technology will increase 
our understanding of human embryo implantation and aid clinicians in counseling and treating 
patients suffering from infertility. 
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14.0 Supplementary Figures 
Supplementary Table 1:  List of significantly altered transcripts between AMA and donor control 
(DC) blastocysts (Q < 0.05). 
https://drive.google.com/file/d/1yjS2nK_5A5-98k7zjHfX4RiOZlbzc4Pg/view?usp=sharing 
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Supplementary Figure 1:  Gene density for all 22 autosomes and chromosome X. Grey shaded 
area represents the 95th percentile, or the area where transcription changes would fall under 
normal chance. Differentially expressed transcripts in AMA blastocysts (orange line) that fall 
above or below the shaded area are considered to have a statistically higher or lower abundance 
in that region of the chromosome (Q < 0.05).  McCallie et al. 2019. 
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Supplementary Figure 2: Top five predicted upstream regulators that lead to the observed 
differences in downstream RNA expression in AMA blastocysts vs. donor control (DC) blastocysts. 
Orange represents an increase and blue indicates a decrease. (a) Alpha catenin and miR-218 are 
predicted to be activated which inhibits downstream transcription. (b) Activation of alpha catenin 
along with de-activation of the NFkB complex, CCL5, and LTB4R inhibit or activate downstream 
transcription. (c) Activation of alpha catenin combined with de-activation of ERG, PEPL1, and the 
PI3K complex result in decreased downstream transcription. (d) Activation of FBN1 and de-
activation of ITGA5, NRG1, CCL5, and PAX7 lead to decreased downstream transcription. (e) 
Activation of alpha catenin, miR-218, and SIGIRR along with de-activation of Hbb-b2 and CCL5 
inhibit downstream transcription.  McCallie et al. 2019. 
Supplementary Figure 2a: 
https://drive.google.com/file/d/1SevnI2G4idtLRp8JI-n2NkrQbUsXd1EE/view?usp=sharing 
 
Supplementary Figure 2b: 
https://drive.google.com/file/d/1Wovqm3qMf-agsjqOHciQ0bsEdhIIXfMe/view?usp=sharing 
 
Supplementary Figure 2c: 
https://drive.google.com/file/d/1gFcgn1xJeohpGbXpS52SSxMw6mVDxsFH/view?usp=sharing 
 
Supplementary Figure 2d: 
https://drive.google.com/file/d/1cDojeR5R60H_j2RG46h1Q-oZKMJFAP2q/view?usp=sharing 
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